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“Will they die?” 
“Difficult to see. Always in motion is the future.” 
Luke Skywalker and Yoda in Star Wars: Episode V 
  
  
ABSTRACT 
Aim 
The aim of this thesis was to assess the role of standardised instruments in prediction of 
suicide attempt and suicide in patients known to have an increased risk of these outcomes, 
namely patients with self-harm. 
Method 
The predictive abilities of four instruments focusing on different factors related to suicide risk 
were estimated using a sample of patients with a recent episode of self-harm with or without 
suicidal intent (N=804) who took part in a prospective, observational multicentre study. 
Patients were identified at psychiatric or medical emergency departments and interviewed by 
research staff not engaged in the regular clinical management. The outcomes of interest were 
suicide attempt and suicide within one year of the index episode. Follow-up data was 
collected from medical records and the National Cause of Death Register. Correlations 
between total scores of the instruments (or dichotomised total scores) and the outcomes were 
evaluated using the χ2-test, logistic regression and receiver operating characteristic curves. 
The Karolinska Interpersonal Violence Scale (KIVS) was used to assess experience of 
interpersonal violence, and the total score was examined as a predictor of repeat non-fatal or 
fatal attempt within six months in 355 participants included after a suicide attempt from 2012 
to 2014 (Study I). The Columbia-Suicide Severity Rating Scale (C-SSRS) was used to assess 
suicidal ideation and behaviour and examined as a predictor of repeat non-fatal or fatal 
attempt within six months in the full sample (N=804) included between 2012 and 2016 
(Study II). The KIVS, the C-SSRS, the Suicide Intent Scale (SIS) and the Suicide Assessment 
Scale (SUAS) were compared regarding predictive accuracy measures for suicide attempt and 
suicide as separate outcomes within three months and one year (Study III). The predictive 
accuracy of the clinical suicide risk assessment was compared to that of SIS in a subset of the 
sample (n=479) for the outcome suicide within one year (Study IV). 
Results 
The non-fatal one-year repetition rate was 27% and the fatal repetition rate was 2.4%. 
Statistically significant correlations were found between the total scores of the KIVS, the 
C-SSRS and the SUAS and non-fatal suicide attempts within six months and one year follow-
up (Study I, II and III). Predictive accuracy was limited for all instruments. The same applied 
to the SIS total score predicting suicide within three months and one year (Study III). The 
predictive abilities were very similar for the SIS and the clinical risk assessment regarding 
suicide during one-year follow-up, again with limited accuracy measures (Study IV). 
Conclusions 
Due to limited accuracy measures and the low base rates of suicide attempt and suicide, these 
instruments cannot be of clinically practical use in the prediction of suicide attempt and 
suicide on an individual level. Other potential areas of usage for the instruments, such as 
structuring clinical data, exploring specific experiences or monitoring symptoms, remain to 
be examined.  
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1 INTRODUCTION 
“Ah. I wondered when you would call.”  
On opening the medical record to re-schedule an appointment, I was met by the strange sound 
and red sign that accompanies the word “Deceased”. Much saddened by this message, but not 
surprised, I called the closest relative of the patient, who greeted me with the above line and 
told me what had happened a fortnight before. The patient, a young person with a psychotic 
disorder, had died by suicide during the initial days of relapse. There had been suicide 
attempts before, all during psychotic episodes. The patient and I had discussed this about ten 
months earlier, when my patient had decided to quit medication – we agreed that the risk of 
suicide would be high in case of a new psychotic episode. We did not agree on the risk of 
relapse. Having made accurate predictions in both cases brought me no satisfaction, just a 
feeling of deep sorrow.  
I entered this doctoral project as a clinician with experience of a so called high-risk group in 
terms of suicide: persons with first episode psychosis. This is not a large group and I have the 
privilege of being able to follow my patients closely. The descriptions of suicidality they had 
shared with me had left me with the impression that suicide risk was inherently difficult to 
assess and above all to manage: many told of suicidal ideation that came upon them as the 
psychotic symptoms worsened, sometimes escalating within hours or just minutes, driving 
them to severe suicide attempts. There seemed to be limited possibilities of detection or 
intervention if the process was so fast. But maybe suicide risk assessment was more feasible 
in other clinical settings, and maybe the standardised instruments I knew existed but rarely 
found use for were much more helpful in other patient groups? With this admittedly 
somewhat sceptical attitude, I started out.  
1.1 TERMINOLOGY 
“Comme le mot de suicide revient sans cesse dans le cours de la conversation, on pourrait 
croire que le sens en est connu de tout le monde et qu'il est superflu de le définir.” 
 Émile Durkheim, 1897 (1) 
Many attempts have been made to suggest a common terminology in the field of suicide 
research (2-6) but at present, parallel definition systems exist. The World Health 
Organization (WHO) defines suicide as “the act of deliberately killing oneself” and suicide 
attempt as “…intentional self-inflicted poisoning, injury or self-harm which may or may not 
have a fatal intent or outcome” [emphasis added](7). They recognise the complications that 
may arise from including events without suicidal intent, but since suicidal intent can be 
“surrounded by ambivalence and even concealment” find it the most suitable definition for 
their purposes. The Centers for Disease Control and Prevention (CDC, a branch of the US 
Department of Health and Human Services) has a definition of suicide that resembles that of 
the WHO: “death caused by self-directed injurious behavior with an intent to die as a result of 
the behavior” but a more narrow definition of suicide attempt: “a non-fatal, self-directed, 
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potentially injurious behavior with an intent to die as a result of the behavior; might not result 
in injury” [emphasis added](8). The International Statistical Classification of Diseases and 
Related Health Problems, 10th Revision (ICD-10) provides standardised diagnostic codes for 
intentional self-harm (X60–X84) and poisonings and other events of undetermined intent 
(X40–X49, Y10–Y34) which can be used for both fatal and non-fatal acts. The intent here 
refers to the act of self-harm being intentional rather than unintentional, i.e. an accident. An 
intent to die as a result of an act cannot be derived from the ICD-10 codes alone. 
It is difficult to assess the intent of someone’s actions, and for this reason many prefer the 
term self-harm for all self-injurious behaviours – a definition found in the guidelines of the 
British National Institute of Health and Care Excellence, NICE (9) and used by many 
European researchers in the field.  
Others, among them many US researchers, find the distinction between acts with and without 
suicidal intent important to maintain, and so differentiate between suicide attempt and non-
suicidal self-injury, NSSI. The latter term unfortunately has at least two definitions, one 
which only includes injuries to the skin (by cutting, burning, biting etc.) (10), and one which 
includes self-injury with any kind of method (11). Since 2012, the Food and Drug 
Administration (FDA, another branch of the US Department of Health and Human Services) 
demands that suicide-related adverse events in clinical trials are classified according to a 
specific set of criteria, the Columbia Classification Algorithm of Suicide Assessment 
(C-CASA) (6, 12). This has led to a widespread use of the corresponding interview 
instrument, the Columbia-Suicide Severity Rating Scale (C-SSRS) (13). This instrument 
defines an actual suicide attempt as a potentially self-injurious act committed with at least 
some wish to die as a result of act (i.e. very similar to the CDC definition). It also adds two 
new categories: aborted and interrupted suicide attempt, to define situations where a person 
“begins to take steps toward making a suicide attempt” but either stops wilfully or is 
interrupted by someone else. Non-suicidal self-injury is also assessed by the C-SSRS, defined 
as intentional self-injurious behaviour, regardless of method, with no intent to die as a result. 
It remains to be seen if this terminology will permeate future suicide research, but 
considering the criticism (14) and competing instruments (15, 16) it seems unlikely to happen 
in the near future. 
The terms suicidal ideation (SI) and suicidal behaviour (SB) are often seen, sometimes 
combined as suicidal ideation and behaviour (SIB). Suicidal ideation usually means thoughts 
about wanting to be dead, thinking one would be better off dead, wanting to die by suicide or 
having plans for a suicide attempt. Suicidal behaviour is loosely if at all defined and can be 
used for suicide attempts, having made preparations for a suicide attempt, self-harming 
without suicidal intent and preparing for but not following through with a suicide attempt.  
Unless otherwise specified, suicide attempt is used in the following text when there is 
evidence of some intent to die as a result of the act. Non-suicidal self-injury is used when 
there is evidence that death was not intended, and self-harm is used for acts with and without 
intent to die.  
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1.2 EPIDEMIOLOGY 
1.2.1 Global estimates 
1.2.1.1 Suicide 
Suicide is a rare event accompanied by tremendous grief in those bereaved, and a strong 
desire to understand, explain and prevent it from ever happening again. It is estimated that for 
every suicide, five immediate family members are affected (17). The World Health 
Organization (WHO) estimated that almost 800,000 persons died by suicide in 2016 which 
translates into an annual global age-standardised suicide rate of 10.5 suicides/100,000 persons 
and year (18). A recent review of suicide mortality found that this rate decreased with 32.7% 
between 1990 and 2016 (19). This reflects the substantial reduction in suicide rates in China 
and India, which (at least in China) has been attributed to an improved socio-economic 
situation. Denmark has also had a marked reduction in suicide rate (60%). Further, it was 
noted that the decline in global suicide rates during this period was more pronounced in 
women (49%) than men (24%). In the US however, rates have increased by 1.5% per year 
since 2000, with regional differences where some states have seen an increase in suicide 
rate  >30% for the period 2000–2016 (20). 
There are large variations among countries with some of the highest suicide rates in men 
observed in Russia, Lithuania and Guyana (48.3, 47.5 and 46. 6/100,000) with a 
male-to-female ratio of 3–7:1 (18). The highest suicide rates for women are seen in Lesotho, 
Uganda and Liberia (35.4, 18.7 and 17/100,000) with a female-to-male ratio of 0.8–1.4:1. 
The lowest rates reported are zero, which is interpreted as underreporting due to either lack of 
reliable mortality statistics and/or the fact that in some countries, suicide is highly stigmatized 
and in some places even illegal. Apart from stigma and legal issues, there are differences 
among countries regarding routines for cause of death certification, which also could affect 
the suicide rate (21). 
Estimates of differences between regions from 2012 indicate that the suicide rate is similar in 
high and low income regions (12.7 and 13.4/100,000) with lower reported rates in 
upper-middle income countries (7.4/100,000) (7). The gender difference seen in high income 
countries, where the male-to-female ratio is 3.5:1, is not seen in other regions where ratios of 
1.3–1.9:1 are reported.  
In a review of psychological autopsies (interview studies with next-of-kin to suicide 
decedents, where information not present in e.g. registers can be obtained), medical record 
reviews and other study types, Luoma and co-workers found that on average, 19% of suicide 
decedents had been in contact with a mental health provider within a month of their suicide, 
and 45% had seen a primary care provider during the same period (not necessarily for mental 
health issues) (22). Corresponding figures for contact within a year of suicide were 24% for a 
mental health contact and 62% for primary care. 
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1.2.1.2 Non-fatal self-harm and suicidal ideation 
The annual rate of non-fatal self-injurious behaviours is more difficult to assess. This is due 
both to the varying definitions in use (which may or may not correspond to e.g. diagnoses in 
registers) but also to the fact that these events are not registered in the same way as suicide. 
Hospital records and registers can be used, but these can only give information about persons 
who have contact with the health care system in conjunction with a self-harm event. Help-
seeking after self-harm has been assessed in mainly adolescent and young adult samples, 
indicating that less than 50% of those who self-harm seek professional help (23).  
Based on mental health surveys conducted in different countries and regions, the WHO 
estimates a global annual rate of suicide attempt (which, by their definition, includes events 
without suicidal intent) of 4/1,000 in adults (>18 years) (7). A cross-national survey study 
based on almost 85,000 individuals in 17 countries in Africa, the Americas, Asia and the 
Pacific, Europe and the Middle East suggested that the lifetime prevalence of suicidal 
ideation and suicide attempts was 9.2% and 2.7% (24). The same study reported that about a 
third of those with suicidal ideation will make a suicide attempt, and that more than 60% of 
these transitions from thoughts to attempt will occur within the first year of ideation onset. 
A European survey study based on ca 25,000 persons reported an adult lifetime prevalence of 
suicidal ideation and suicide attempts of 7.8% and 1.3% (25).  
In an English survey from 2014, separating suicide attempts and self-harm without suicidal 
intent, lifetime prevalence of suicide attempt was 6.7%. Self-harm without suicidal intent was 
reported by 7.3%, and 20.6% had had suicidal thoughts (26). In another recent survey of 
18–34 year old persons in the UK, 11% reported having made a suicide attempt and 16% 
reported a previous non-suicidal self-harm, 3% and 5% within the past year. Almost 25% 
reported suicidal ideation at some point in life (27).  
1.2.1.3 Non-fatal and fatal repetition 
In two systematic reviews, covering the literature from 1970 to 2012, the median incidence of 
non-fatal repetition of self-harm was 16% at one year and about 22–23% at 5 years (28, 29). 
Cohorts with above-median proportion of persons with more than one previous self-harm 
event had a one year repetition rate of 19%, significantly higher than cohorts with a larger 
proportion of first-time self-harm where the repetition rate was 15% (29). Cohorts in which 
repetition was identified by hospital attendance had a repetition rate of 17%. If repetition was 
identified only by hospital admittance, repetition rate was 13%, and if self-report by patients 
was used, repetition rate was 22% at one year (29). In one study evaluating time to non-fatal 
repetition in a sample of hospital-presenting persons with self-harm, the median time to 
repetition was 12 weeks (30). 
The median incidence of suicide at one year after self-harm was 1.6–1.8%. The one-year 
estimate for men was 2.7% compared to 1.2% in women. Cohorts with an above-median age 
had a one year repetition rate of 2.4% compared to 1.1% in younger cohorts. Suicide risk 
persisted over time with a median incidence of 4.2% at 10 years (29) and 6.7% after 9 years 
(28). 
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1.2.1.4 Gender differences 
A consistent finding in official statistics and scientific studies is that non-fatal self-harm is 
more common in women whereas suicide is more common in men. This has been explored in 
a large amount of studies and among the proposed explanations are differences in 
help-seeking (31) and help-accepting behaviour and openness to consideration of the advice 
of others (32), cultural norms regarding acceptable behaviour (33), suicidal intent (34-37), 
and method choice (38). In a systematic review on risk factors for non-fatal repetition of 
self-harm, 68 studies exploring the effect of gender were found, with contradictory evidence 
as to if or how gender affects the risk of repetition (39). 
1.2.2 Swedish statistics 
At the end of 2016, 9.99 million persons lived in Sweden (40). During 2017,  
1,189 (0.01%) of them died by suicide (ICD-10 codes X60–X84) (41). The majority, 70%, of 
all suicide deaths occurred in men, and men had higher suicide rates in all age categories 
compared to women except in ages 10–14 where the absolute numbers are very small and a 
single case has a large impact on the rate. Suicide is the most common cause of death in 
women aged 15–29 with 70 suicides in 2017, compared to 156 suicides in men the same age, 
who more commonly die in accidents. The age-standardized suicide rate for the Swedish 
population in 2017 was 11.8/100,000 (41). This rate has decreased since the 1980s, to the 
largest extent in older men who despite this still have the highest suicide rates. In some 
presentations on suicide statistics, deaths caused by poisoning and events of undetermined 
intent (ICD-10 codes X40–X49 and Y10–Y34) are included, for instance in statistics from the 
National Centre for Suicide Research and Prevention of Mental Ill-Health (NASP). 
According to their web page, this is based on studies indicating that as many as 70% of the 
events of undetermined intent probably are suicides (42). However, a recent study on suicide 
statistics in the Scandinavian countries found that in Sweden, 80% of the suicides were 
correctly classified while only 20% of the events of undetermined intent should be 
reclassified as suicides, with little impact on the overall suicide rate (43). In 2017, 355 
persons died in an event of undetermined intent (41). Trends over time are presented in 
Figure 1, where moving means of the suicide rate have been used to smooth out short-term 
trends.  
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Figure 1. Moving means superimposed on annual suicide rates/100,000 persons and year in different 
age groups in Sweden during 1980–2017. From https://ki.se/nasp/statistik. 
 
In 2017, 6,800 persons were admitted to Swedish hospitals with a diagnosis of intentional 
self-harm, 1,365 (20%) of whom were women aged between 15 and 24 years (44). Hospital 
admission with intentional self-harm is more common in women than in men in all age 
groups. For both men and women the rate of hospital admission after self-harm has declined 
somewhat during the last years, which could be due to changes in clinical management 
routines, shifting from inpatient to outpatient treatment (44).  
The Public Health Agency Sweden (Folkhälsomyndigheten) issues a health survey every 
second year since 2004. In 2016, 13% of the respondents reported that they had experienced 
suicidal ideation at some point during their lives, and of these, 3% reported suicidal ideation 
during the past year (45). Almost 25% of female and 20% of male respondents aged 16–29 
years reported life-time ideation compared to 6% of respondents aged 65–84 years. 
Regarding suicide attempt, 4% of the women and 3% of the men reported having made a 
suicide attempt at some point during their lives. Of those with life-time suicidal ideation, 28% 
had made a suicide attempt.  
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1.3 CORRELATES AND RISK FACTORS OF SUICIDE ATTEMPT AND SUICIDE  
Many factors are described as risk factors for suicide and suicide attempt. The term itself 
deserves some attention. In 1997, Kraemer and co-workers described a risk factor typology 
according to which a correlate is a factor associated with another factor, but where it is not 
known how and why the factors are correlated (46). A risk factor is a correlate that is present 
before an outcome of interest. A risk factor that cannot be manipulated (like year of birth) is a 
fixed marker. A risk factor that can change or be changed (like age or weight) is called a 
variable risk factor – which could turn out to be a causal risk factor if 1: it can be 
manipulated and 2: the probability of the outcome systematically changes when the variable 
risk factor is manipulated. Using this typology, there is a large body of research on correlates 
and risk factors for suicide attempt and suicide (47).  
Another general aspect of risk factor research is how the amount of exposure to a specific risk 
factor is evaluated. The exposure can be characterised in different ways (age at first exposure, 
total amount of time under exposure, largest dose, current dose etc.) and if the correct 
measure is not chosen, a correlation between a risk factor and a negative outcome may not be 
detected (48). 
1.3.1 Biological markers 
Different biological factors have been studied as potential biomarkers or risk factors of 
suicide attempt and suicide – cholesterol, glucose, 5-hydroxyindoleacetic acid levels in 
cerebrospinal fluid, oxytocin, different cytokines, genes for e.g. the serotonin transporter, 
different nutrients – many however in cross-sectional studies with limited capacity for finding 
causal relationships. In a meta-analysis of longitudinal studies on biological factors 
(85 proposed risk factors, 9 proposed protective factors), the weighted mean odds ratio of all 
proposed risk factors was 1.41 for suicide attempt and 1.28 for suicide, none remaining 
significant after accounting for publication bias (49). Two single factors (with only one study 
each) remained significantly associated with suicide: one cytokine; vascular endothelial 
growth factor (50) and low levels of fish oil nutrients (51).  
1.3.2 Experience of interpersonal violence 
A recent meta-analysis and systematic review on the effect of childhood maltreatment on 
adult suicidality showed that all types of abuse (emotional, physical and sexual) increased the 
risk of both suicidal ideation and suicide attempts by 2–3 times (52). There is also evidence 
that intimate partner abuse in adulthood increases the risk of suicide attempt (53). Verbal 
aggression, hostility, easily evoked anger and use of physical violence have all been shown to 
correlate with both suicide attempt and suicide in longitudinal studies (54). Bullying has also 
been studied, and being both a victim and a perpetrator is associated with increased risk of 
suicidal ideation and behaviour (55).  
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1.3.3 Psychiatric and other disorders 
It is estimated from psychological autopsies from mainly Western European and US samples 
that a psychiatric disorder is present in 90% of suicide cases (56). Affective disorders are the 
most common in suicide decedents, followed by substance use disorder and schizophrenia 
(56). Almost every psychiatric disorder is associated with an increased risk of suicide (57, 
58). Substance use disorders (particularly relating to opioids), anorexia nervosa and 
borderline personality disorder are among the conditions with the highest increase in lifetime 
risk.  
Further, psychiatric inpatient care regardless of diagnosis as well as recent admission and 
discharge have all been correlated with an increased risk of suicide (57, 59-61). There is an 
ongoing debate on whether this is merely a consequence of selection bias, that the admitted 
patients are the most severely ill ones, or if the experience of hospital treatment in itself 
contributes to the increased risk (62).  
The impact of psychiatric disorder and gender on the risk of suicide after self-harm has also 
been explored. In a large Swedish register study on patients admitted to hospital after 
self-harm in 1973–1982, with a follow-up time of 21 to 31 years, the male one-year incidence 
of suicide was 23% in bipolar and unipolar disorder, 22% in schizophrenia and 8% in anxiety 
disorders (63). Corresponding figures for women were 8.5%, 13% and 3%. Hazard ratios 
(HR) for the entire follow-up period ranged from 1.5 (anxiety disorder in women) to 4.1 
(schizophrenia in men). Similar risks were found for a more recent cohort admitted after 
self-harm in 2000–2005 (64).  
The influence of method of self-harm according to gender and diagnosis has also been 
studied in the hospital-treated cohort from 1973–1982. The male and female one-year 
incidence of suicide after a hanging attempt was 47% and 48% (65). About one quarter of 
men who used violent self-harm methods (drowning, shooting or jumping) died by suicide 
within one year. The corresponding figures for poisoning or cutting was 3–4%. 
Corresponding figures for suicide incidence in women were 34% during the year after a 
drowning attempt and 15% after jumping from height, compared to 2–3% for poisoning and 
cutting. When psychiatric diagnosis was added, the one-year suicide incidence after a 
hanging attempt was 69% in men and women with a psychotic disorder (e.g. schizophrenia), 
and about 50% in men and women with an affective (bipolar and unipolar) disorder (65). 
Method at non-fatal self-harm and subsequent risk of suicide has also been studied in a cohort 
of children and young adults (10–24 years) who were treated after self-harm in specialist 
(non-psychiatric) health care between 2000 and 2009. The suicide risk was increased in those 
who were admitted to hospital care after self-harm with a violent method, and this was also 
observed for young women hospitalised after self-harm by cutting (66). 
Many somatic disorders, e.g. neurological conditions such as Huntington’s disease and 
multiple sclerosis, different types of cancer, pulmonary disease, HIV/AIDS and stroke have 
been shown to increase the risk of suicide, highlighting the need for suicide risk management 
in primary and specialised somatic care settings (67, 68). 
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1.3.4 Symptoms and cognitive features 
Apart from diagnoses, specific symptoms or cognitive features have been studied in relation 
to suicide attempt and suicide. Hopelessness has been shown a stronger correlate of suicidal 
ideation, suicide attempt and suicide than a diagnosis of depression in various clinical 
samples of suicide attempters (69, 70). In a retrospective study of the medical charts of 
inpatient suicides, 79% had signs of severe anxiety or agitation in the week before the 
suicide, however no controls were included in this study (71). In a meta-analysis of controlled 
studies, anxiety and agitation were correlated to in-patient suicide with an OR of 2.13 (72). 
Cognitive rigidity and poor problem solving has also been associated with suicidal ideation 
and behaviour (73), as well as perfectionism (74, 75), rumination (76-78) and cognitive and 
behavioural impulsivity (79). Insomnia and nightmares were highly prevalent in a sample of 
suicide attempters (80). Sleep disturbances in general have been correlated with an increased 
suicide risk (81) as has chronic pain (82). 
The problem with reliance on self-report regarding e.g. suicidal ideation has been identified, 
and attempts have been made to assess suicidality without asking about it explicitly. The 
Implicit Association Test (which evaluates thoughts and feelings that are largely outside of 
conscious awareness and control) has been modified to test the association between self and 
death/suicide (83). In a study on suicide attempters, it was shown that a strong implicit 
association of death with self was associated with increased risk of a reattempt within six 
month. 
1.3.5 Interpersonal problems 
Interpersonal conflicts have been found to increase the risk of both initiation and repetition of 
self-harm (55, 84, 85) and lower perceived peer support is more prevalent in young adults 
who self-harm (86). In a sample of almost 25,000 adult, hospital-treated self-harm patients, 
relationship problems were identified as the most common life problem in connection with 
the self-harm event (87). Interpersonal problems but also increased loneliness, social isolation 
and perceived loss of control were found to be correlated to suicide attempt in a systematic 
review on risk factors in older adults (all aged 60 years and above) (88). 
1.3.6 Previous self-harm 
Previous self-harm is often described as a major risk factor for both repetition of self-harm 
and suicide (28-30, 89-92). In a systematic review of psychological autopsy studies, it was 
estimated that at least 40% of those who die by suicide have a history of self-harm (56). 
When the prognosis after non-fatal self-harm is studied prospectively, 1–6% die by suicide 
during the first year, suggesting an increased suicide risk of 50–100 times compared to the 
general population (28, 93).  
1.3.7 Specific risk factors for repetition? 
Apart from previous self-harm, which for obvious reasons cannot be a risk factor for a 
first-time self-harm event, there is no convincing evidence of risk factors unique to repetition 
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of self-harm. The factors most consistently correlated to non-fatal repetition are previous 
self-harm, having a psychiatric disorder (including substance use), being in psychiatric 
treatment and being a victim of sexual abuse (39, 94). Risk factors for fatal repetition 
includes older age, previous self-harm, suicidal ideation, living alone, being male and having 
a substance use disorder. 
1.4 UNDERSTANDING SUICIDE 
In early philosophical and religious traditions, from the ancient Greek and through Judaeo-
Christian and Muslim thinking, suicide was often (and still is, in some communities) 
considered a crime and/or a sin. It could be seen as taking a liberty one did not have since 
one’s life belonged to one or many gods (both Plato and St Thomas Aquinas expressed this 
view) (95) and being desperate enough to attempt suicide could also be seen as an almost 
heretic lack of trust in divine mercy. Some pointed out that the delicate balance of the 
universe would be disturbed if a soul or a person suddenly disappeared (the Pythagoreans as 
well as later thinkers proposed this) (95, 96). Early suicide preventive strategies included 
stigmatization, punishment of persons attempting suicide, degrading the remains of persons 
who had died by suicide and maltreatment of those bereaved (95). Parallel to this, an 
understanding could be expressed for suicides in certain situations, such as being sentenced to 
death by suicide (which condoned the suicide of Socrates) but there is also evidence that 
extreme personal circumstances that could have included severe mental disorders could 
invoke a less repressive response (95, 97). In the late 1700s, suicide began to be 
conceptualised as a sign of mental disorders, at least in parts of Western societies, and the 
idea of suicide as a crime was challenged.  
In 1897 Durkheim considered the phenomenon from a sociological point of view. He defined 
suicide as all deaths where death was chosen over life, i.e. also soldiers in war, martyrs, 
sacrificing one’s life for something or someone else. He identified four suicide types based on 
aspects of social integration (to what extent a person has ties to a social group) and regulation 
(normative and moral demands of the group, which must be met by its members) but rejected 
the idea that all suicides were caused by psychiatric disorders (1, 98).  
In more recent decades, several models have been presented. Most of them describe suicidal 
behaviour as a result of an interaction between predisposing and precipitating factors with 
different emphasis on how the transition from ideation to action comes about (99). Many of 
them have a high face validity in explaining suicide, and some of them are researched for 
empirical evidence, but there has been little if any comparative research into which model is 
the most accurate (47). It should be noted that they are mostly conceptual models aimed at 
understanding suicidal behaviour, not mathematical models aiming at predicting it, so it 
follows that comparison will be difficult. Here, some of them are described. 
Shneidman described suicide as a result of psychache, an intolerable psychological pain that 
cannot be dealt with. While the individual may not necessarily wish to die, suicide seems like 
the only solution (100). Schotte described a diathesis-stress-hopelessness model emphasising 
cognitive rigidity and poor problem solving skills as factors associated with suicide risk (101) 
and a variant of this model has also been described by Mann (102). 
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The interpersonal-psychological theory states that a suicide can only occur if there is both 
desire to die by suicide (which stems from a perception of being disconnected, no longer 
belonging in the company of others, and being a burden to them) and a capability to act on 
that desire (103). The capability consists of two dimensions, lowered fear of death and 
increased tolerance to physical pain and is, according this theory, acquired by repeated 
exposure to painful and provocative events, e.g. interpersonal violence, combat exposure and 
previous suicide attempt. Many studies have been published on this theory, including some 
questioning its claims (104, 105).  
Michel and members of the Aeschi Working Group emphasise the importance of exploring 
the intersubjective meaning of the suicide attempt, i.e. an act needed to be understood in the 
context in which it developed rather than a symptom of a psychiatric disorder (106). This 
model has direct implications for treatment, focusing on the patient’s detailed narrative of the 
circumstances of a suicide attempt, and the development of an individual safety strategy.  
Another model, which attempts to combine components from previous models into one, is the 
integrated motivational-volitional model, which is presented in Figure 2 (107). It includes 
“moderators”, factors that affect the likelihood of transition from phase to phase. 
 
 
 
Figure 2. The integrated motivational-volitional model, adapted from O’Connor. 
 
Difficulties in problem-solving, poor coping skills and rumination are described as “threat-to-
self” moderators, contributing to feelings of entrapment. Motivational moderators, e.g. 
perceptions of the future and social support (or lack thereof) give way to suicidal ideation, but 
for the transition from ideation to action to occur, some volitional moderator such as acquired 
capability, impulsivity or planning and access to means must be present.  
1.5 STANDARDISED INSTRUMENTS USED IN SUICIDE RISK ASSESSMENT 
One of the first suicide risk assessment tools was constructed in 1963 by the Los Angeles 
Suicide Prevention Center, to be used to evaluate risk in persons calling the centre. An 
Triggering life 
event
Diathesis, early 
life events, 
environment
Defeat, 
humiliation
Rumination, 
poor coping 
skills →
Entrapment
Future goals, 
lack of support 
→
Suicidal 
ideation
Impulsivity, 
planning, aquired 
capability, access 
to means →
Suicide 
attempt
Volitional phase 
Motivational phase 
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instrument proposed for clinical settings was presented in 1968 (108) and since then, many 
have followed. Examples include the Suicide Intent Scale and the Suicide Assessment Scale 
(both described in more detail in the Method section) (109, 110), the Beck Scale for Suicide 
Ideation (111), the SAD PERSONS scale (112), the Manchester Self-Harm Rule (113) and 
the ReACT self-harm rule (114). They are similar in the overarching structure of being 
mainly characteristics of the person under assessment, correlated to suicide attempt or 
suicide. Some are checklists assessing the presence or absence of specified thoughts, feelings, 
behaviours and/or outer circumstances whereas some add a range to the factors in terms of 
proposed severity. A total score is yielded by addition of item scores. Clinician- or 
system-related risk factors, such as clinician fatigue or lack of hospital beds or skilled 
psychotherapists, are rarely assessed (115). 
Other instruments not specifically focused on suicide have also been used in suicide 
prediction studies, for instance the Beck Depression Inventory (rating severity of depression) 
(116) and the Beck Hopelessness Scale (rating hopelessness and pessimism) (117). 
Some instruments use weighting of the items and take interaction effects into account. One 
example is Motto's risk estimator for suicide, using 15 variables including the interviewer’s 
reaction to the patient to give a two-year risk of suicide (118). A very recent publication 
presents the derivation and validation of an algorithm using a Swedish cohort of patients with 
schizophrenia and bipolar disorder, giving an estimated one-year risk of suicide (119). A 
suicide risk calculator based on this study is available online (120). 
1.5.1 Responding and reacting to questions about suicidality 
Even though a standardised interview instrument gives a more structured output than the 
clinical interview, both rely on patient self-report, the quality of which depends on the 
patient’s honesty, introspective capacity, ability to understand the questions and to recall 
details on thoughts and feelings from weeks ago. All these can be affected for various reasons 
including ongoing symptoms that colour the memory of previous experiences, impaired 
episodic memory, not wanting to disclose specific issues or wanting to emphasise others. If a 
self-rated instrument is used one also has to acknowledge different ratings styles that might 
be associated with personality traits, such as being an extreme responder, or always choosing 
an alternative close to the median.  
Regarding self-reported suicidality, one study on a sample of undergraduate students with a 
life-time history of suicidal ideation found that disclosure was most accurate to mental health 
professionals, and least accurate to family members (121). Barriers to disclosure were fear of 
worrying family members, fear of being hospitalised and fear of experiencing embarrassment 
during therapy. An expression of empathy was however the most common response from 
both professional caregivers and family members. In a qualitative study on men aged 60 and 
above with an ongoing or recent depressive episode, 98% expressed a positive attitude to 
discussing suicidal ideation with their general practitioner (122). A positive attitude to suicide 
screening was also found in a sample of medical emergency seeking patients (123). More 
hesitant attitudes were observed in a study involving US Army veterans (124). Feelings of 
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inadequacy and shame associated with suicidal ideation were identified as barriers to 
disclosure, as was uncertainty about confidentiality. The genuineness, empathy and 
straightforwardness of the health care professional were cited as vital to disclosure. In a large 
Dutch population survey study, suicidal ideation disclosure was associated with poor health 
including psychological distress and frequent suicidal ideation (125). Being male, of older 
age, having a lower education level and poor social connectedness were factors associated 
with increased odds of non-disclosure of suicidal ideation in a large French mental health 
survey (126). Several studies have explored the impact of asking about suicidal ideation and 
behaviours and there is of yet no evidence that this initiates or increases suicidal 
ideation (127-131). 
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2 AIMS 
The aim of this thesis was to evaluate the ability of different assessment instruments to 
predict suicide attempt and suicide in a psychiatric cohort within up to one year after an event 
of self-harm with or without suicidal intent, to study if it were possible, in a clinically 
meaningful way, to identify those with the highest risk within this high-risk group. The 
research questions of the specific studies were: 
Study I: Is experience of interpersonal violence, assessed with the Karolinska Interpersonal 
Violence Scale (KIVS), associated with an increased risk of non-fatal or fatal suicide attempt 
within six months of a suicide attempt? If so, to what extent? 
Study II: Can the characteristics of suicidal ideation and behaviour, measured with the 
Columbia-Suicide Severity Rating Scale, (C-SSRS) predict non-fatal or fatal suicide attempt 
within six months of a self-harm event? If so, to what extent? 
Study III: Are there any differences in the predictive abilities of the Suicide Intent Scale 
(SIS), the Suicide Assessment Scale (SUAS), KIVS and C-SSRS in predicting suicide 
attempt and suicide within three months and a year? If so, are any of these instruments 
clinically useful for this purpose? 
Study IV: How does a clinical suicide risk assessment compare to the well-established SIS in 
predicting suicide during a follow-up time of one year after a self-harm event? Is predictive 
accuracy increased if these assessments are combined? 
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3 MATERIAL AND METHODS 
 Study I Study II Study III Study IV 
Research focus Interpersonal 
violence as predictor 
of suicide attempt 
Suicidal ideation and 
behaviour as 
predictor of suicide 
attempt 
Comparison of 
predictive accuracy 
of assessment scales 
Clinical suicide 
risk assessment vs 
Suicide Intent 
Scale 
Study design Cohort study Cohort study Cohort study Cohort study 
Study population Individuals with 
suicide attempt in a 
Swedish multi-
centre study,  
2012–2014. 
Individuals with 
self-harm with or 
without suicidal 
intent in a Swedish 
multi-centre study, 
2012–2016. 
Individuals with 
self-harm with or 
without suicidal 
intent in a Swedish 
multi-centre study, 
2012–2016. 
Individuals with 
self-harm with or 
without suicidal 
intent, Stockholm 
subset, 2012–2016. 
Size of study 
population 
355 804 804 479 
Data source Research interview 
and medical records 
Research interview 
and medical records 
Research interview, 
medical records and 
Cause of Death 
register 
Research 
interview, medical 
records and Cause 
of Death register 
Follow-up time Six months Six months Three months, one 
year 
One year 
Predictor/s  KIVS score C-SSRS total score, 
C-SSRS subscale 
scores 
Total scores of SIS, 
SUAS, KIVS and 
C-SSRS 
SIS score and 
clinical risk 
assessment score 
Outcome  Composite outcome: 
Non-fatal and fatal 
suicide attempt 
Composite outcome: 
Non-fatal and fatal 
suicide attempt 
Suicide attempt, 
suicide 
Suicide 
Statistical 
analyses 
χ 2-test, t-test, 
logistic regression, 
ROC curves 
Logistic regression, 
ROC curves 
χ 2-test, Mann-
Whitney U-test, 
ROC curves 
χ 2-test, logistic 
regression, ROC 
curves 
Table 1. Summary of the studies  
KIVS=Karolinska Interpersonal Violence Scale. C-SSRS=Columbia-Suicide Severity Rating Scale. 
SIS=Suicide Intent Scale. SUAS=Suicide Assessment Scale. ROC=Receiver Operating 
Characteristics. 
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3.1 COHORT STUDIES 
All studies in the present project are prospective, observational cohort studies: longitudinal 
studies aiming to assess the impact of one or more specified factors on an outcome of interest.  
A cohort is a group of people sharing some defining feature or experience who are observed 
for a period of time, to see what happens to them. Data can be collected actively from the 
members of the cohort at specific time points, or collected from medical records or registers 
without their active participation (or knowledge), or both, as in the present project. Among 
the data collected are variables that are hypothesised or known to influence the probability of 
an outcome of interest; exposure and control variables. The members of the cohort should be 
free of the outcome of interest at the start of the study, and in an observational study, no 
treatment or exposure is given to them as part of the study. The follow-up time should be 
sufficiently long, given what is known about the natural course of the condition studied and 
the incidence of the outcome observed. The incidence of the outcome in the cohort can be 
compared to that of the general population (from which the cohort was drawn). Alternatively, 
sub-groups within the cohort can be compared to each other. Absolute and relative risks can 
be calculated. The impact of an exposure on the incidence of the outcome can be assessed 
with regression analyses to enable adjustment for other factors known to influence the 
incidence.  
3.2 DATA COLLECTION 
3.2.1 The multicentre study 
This doctoral project is based on a clinical multicentre study conducted in Stockholm, 
Gothenburg and Umeå with inclusion on all three sites between April, 2012 and April, 2016. 
Patients seeking or being referred for a psychiatric evaluation after an event of self-harm with 
or without suicidal intent were considered for inclusion. To enable follow-up through medical 
records and national registers, participants had to be residents of the catchment area of the 
respective sites and have a Swedish personal identity number. Patients with symptoms or 
behaviours interfering with verbal communication (cognitive impairment, psychosis, 
intoxication, aggressiveness) were not considered for inclusion, but a diagnosis of e.g. a 
psychotic disorder was not an exclusion criterion. If the patient was unable to take part in the 
research interview at first arrival to the psychiatric clinic but stayed as an inpatient, they 
could be eligible for participation when the interfering symptoms had resolved. The majority 
of interviews were performed within seven days of the self-harm event.  
The three sites represent somewhat different clinical settings. In Stockholm, the psychiatric 
emergency department situated at St Goran’s Hospital serves all of Stockholm County with 
2.2 million inhabitants. Many patients are assessed there and then transferred within 24 hours 
to one of the psychiatric clinics in Stockholm. One of these, Northern Stockholm Psychiatry 
(Norra Stockholms psykiatri), is administratively connected to the emergency department and 
located on the same premises. Patients belonging to this clinic could also be included if they, 
as inpatients, had had an event of self-harm.  
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In Gothenburg, study participants were identified via a psychiatric consultation team 
connected to the somatic emergency department and wards at Sahlgrenska University 
Hospital. This hospital has a catchment area of ca 400,000 inhabitants. Patients presenting 
directly to the psychiatric emergency department at Östra Hospital after self-harm were not 
available for inclusion.  
In Umeå, the psychiatric emergency department and clinic is the only provider of psychiatric 
inpatient care serving a catchment area of 150,000 inhabitants. Potential study participants 
were identified in the emergency department or at the wards. 
3.2.2 Baseline data 
3.2.2.1 The research interview  
The research interview was carried out by psychiatrists, a psychologist and psychiatric 
nurses. Those unexperienced with the instruments used were given special training and 
supervision. Twenty interviews were performed with parallel ratings for assessment of 
interrater reliability. The interview included questions about method at the index attempt, 
previous suicide attempts and/or non-suicidal self-injury, other health related (e.g. family 
history of or environmental exposure to suicide and suicide attempt, present somatic 
disorders, present or previous contact with psychiatric care) and socio-demographic (e.g. 
living conditions, highest attained educational level, present occupation) factors. Standardised 
instruments were also applied. The interview lasted about 1.5 hours. 
3.2.2.2 The Karolinska Interpersonal Violence Scale  
The Karolinska Interpersonal Violence Scale (KIVS) was originally presented in a study of 
161 suicide attempters where it was shown that high scores predicted suicide (132). The scale 
has four items presented in Table 2, assessing the use of and exposure to violent behaviour in 
childhood (6–14 years) and as an adult (≥15 years).  It is based on a semi-structured interview 
and each item is scored 0–5 giving a range for the total score of 0–20 with higher scores 
indicating more severe forms of violence expressed or experienced. The first study showed 
high inter-rater reliability (r = 0.91–0.95 for the separate items) and the KIVS has been 
validated against more extensive instruments assessing experience of violence such as the 
Buss-Durkee Hostility Inventory (133, 134). It has been used in studies assessing the 
interplay between experience of interpersonal violence, family history of suicide, substance 
use and suicidality (135-138).  
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Expression of 
violence, 6–14 years 
Expression of 
violence, ≥15 years 
Exposure to violence, 
6–14 years 
Exposure to violence, 
≥15 years 
1: Occasional fights 
3: Often started fights 
5: Caused serious 
injury  
1: Occasionally 
slapped or shoved an 
adult 
3: Assaulted partner 
5: Caused severe 
bodily harm, death, 
repeated sexual assault 
1: Occasionally 
slapped 
3: Often bullied, hit by 
parent 
5: Repeated exposure 
to violence or sexual 
abuse 
1: Threatened or 
exposed to low-level 
violence once 
3: Robbed, frequently 
beaten by partner 
5: Repeatedly raped or 
battered, seriously 
injured 
Table 2. The four items of the KIVS, with some examples. 
 
3.2.2.3 The Columbia-Suicide Severity Rating Scale 
The Columbia-Suicide Severity Rating Scale (C-SSRS) presented in Figure 3 evaluates 
suicidal ideation and self-harm behaviours (13). There are two subscales for ideation: severity 
and intensity. The ideation severity subscale ranges from wish to be dead to active suicidal 
ideation with specific plan and intent to act, similar to the “suicide ladder” questions based on 
Paykel’s observation of suicidal feelings occurring on a continuum (139). The ideation 
intensity subscale contains the items frequency, duration and controllability of the most 
severe thoughts. Factors deterring the person from acting are scored as well as reasons for 
ideation. Behaviours are classified as actual, interrupted or aborted suicide attempts, 
preparatory acts or non-suicidal self-injurious behaviour. Actual suicide attempts are 
classified according to actual or potential lethality or medical damage. The C-SSRS has been 
used in prediction studies in mainly adolescent and young adult populations (140-143) with 
one study specifically addressing the risk of repetition of self-harm (13). Since it is originally 
an instrument for classification there are no instructions on how to obtain a total score. One of 
its items is the sum of a subscale, and thus cannot be counted when summing the total score. 
Three other C-SSRS items (numbers of actual, aborted and interrupted suicide attempts) can 
take on a wide range of values. For the purpose of the current studies, this was addressed by 
trichotomising the numbers of actual, aborted and interrupted suicide attempts: 0 (no 
attempts), 1 (1-2 attempts) and 2 (three or more attempts) and these values were applied when 
calculating the total score. Using this approach the total score has a range of 0–42 (144).  
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Figure 3. The items assessed by the C-SSRS. 
 
3.2.2.4 The Suicide Assessment Scale 
The Suicide Assessment Scale (SUAS) was constructed to measure symptoms relevant for 
suicidality independent of other diagnoses (110). It is supposed to be sensitive to change over 
time and evaluates both observed and reported symptoms (145). The 20 items presented in 
Table 3 are scored 0–4, yielding a potential range of 0–80. The items concerns five domains 
(affect, bodily states, control and coping, emotional reactivity and suicidal thoughts and 
behaviour). The inter-rater reliability from the original study was 0.78–0.88 and the criterion 
and concurrent validity was reported to be satisfactory [Stanley, B. et al, The suicide 
assessment scale, Psychopharmacol Bull, 1986 quoted in (145)]. There is also a Norwegian 
version with robust measures of internal consistency, test-retest reliability and concurrent 
validity (146).   
Sadness, despondency 
Hostility 
Lack of energy 
Hypersensitivity 
Emotional withdrawal 
Resourcefulness 
(difficulties in 
problem-solving) 
Perceived loss of 
control 
Physical tension 
Anxiety 
Somatic concern 
Impulsivity 
Low self-esteem 
Hopelessness 
Inability to feel 
emotions 
Poor frustration 
tolerance 
Suicidal thoughts 
Purpose of suicide  
Wish to die 
Lack of reason for 
living 
Suicidal actions 
Table 3. The 20 items assessed by the SUAS. 
Ideation severity
•1: Wish to be dead 
•2: Thoughts of suicide
•3: Thoughts of suicide 
with specific method, no 
intent to act
•4: Thoughts of suicide, 
with specific method and 
some intent to act
•5: Thoughts of suicide, 
specific method, plan and 
some intent
Ideation intensity
•Frequency, 1–5
•Duration, 1–5
•Controllability, 0–5 
where 0=does not attempt 
to control thoughts
•Deterrents, 0–5 where 
0=does not apply
•Reasons for ideation,
0–5 where 0=does not 
apply 
Behaviours,
yes/no. Number of 
attempts scored for all 
kinds of suicide attempt
•Actual suicide attempt, 
•Interrupted suicide 
attempt
•Aborted suicide attempt
•Preparatory acts
•Non-suicidal self-injury
•Medical severity of 
actual attempts is scored 
0–5. If 0, potential 
severity is scored 0–2.
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3.2.2.5 The Suicide Intent Scale 
The Suicide Intent Scale (SIS) has 15 items and was constructed to reflect the degree of 
suicidal intent at a recent suicide attempt (109, 147). The items presented in Table 4 cover 
objective circumstances of the attempt and the person’s expectations and beliefs about the 
attempt. Items are scored 0–2 and the total score has a range of 0–30. It has been widely 
researched: in a review from 2008, 13 studies on suicide prediction and 17 studies on 
prediction on non-fatal repetition were identified, with five studies showing positive 
correlations between high SIS scores and suicide (148). The findings for non-fatal repetition 
were mostly negative. 
The objective items The subjective items 
Isolation 
Timing  
Precautions against 
discovery 
Acting to get help 
during/after attempt 
Final acts in 
anticipation of death 
Active preparation for 
attempt 
Suicide note 
Overt communication 
of suicidal intent 
Alleged purpose of 
attempt 
Expectation of fatality 
Conception of lethality 
of method 
Seriousness of attempt 
Attitude toward 
living/dying 
Conception of medical 
reversibility 
Degree of 
premeditation 
Table 4. The 15 items assessed by the SIS. 
 
3.2.2.6 The clinical risk assessment 
Information about the clinical suicide risk assessment was extracted from medical records at 
the Stockholm site, where doctors are required to choose one of four fixed responses 
(minimal, moderate, high or very high suicide risk). According to the department’s own 
guidelines doctors are encouraged to consider risk factors as well as protective factors, and to 
assess both long and short term risk. There are no explicit instructions on if/how the treatment 
planned in the short time perspective should be taken into consideration when recording the 
risk, and consequently, different approaches exist. 
3.2.3 Outcome data 
3.2.3.1 Medical records 
The final clinical diagnosis made at the time of the index attempt was gathered at the follow-
up evaluation. 
Outcome events were identified by reading all available entries for the follow-up time in the 
medical record. All self-harm events described were recorded with date, method and type of 
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event: suicide attempt, non-suicidal self-injury or self-harm with unknown intent. Since the 
record systems are linked to the Population Register, all deaths during the follow-up period 
could also be registered, however not with a cause of death in all cases. 
3.2.3.2 Cause of Death Register 
The Swedish Cause of Death Register is held by the National Board of Health and Welfare 
(Socialstyrelsen). It contains data on all individuals who have died in Sweden and all deaths 
of Swedish residents, even if death occurred abroad. It is virtually complete regarding the 
number of deaths. A small proportion (<1%) lack an underlying cause of death (149). The 
cause of death for all participants deceased within a year of the index attempt was retrieved 
from this register. 
3.3 STATISTICAL ANALYSES 
Descriptive statistics included calculation of total ranges, means and standard deviations, and 
medians and interquartile ranges.  
Proportions were compared with Fisher’s exact test and Pearson χ2-test. 
Mann-Whitney U-test was used in study III for between-group comparison of distribution of 
ordinal variables. 
Logistic regression was used in studies I–II and IV to assess the influence of continuous and 
non-continuous independent/explanatory variables on a binary dependent/outcome variable. 
Multiple explanatory variables can be analysed at the same time which allows for adjustment 
for potentially confounding factors. A logistic regression yields one odds ratio (OR) for each 
independent variable. The OR answers the question: if the independent variable is increased 
by one unit (e.g. a one-step increment on a rating scale), by how much does the odds of the 
outcome (e.g. suicide) increase or decrease, if the other independent variables are held 
constant? 
The Cox & Snell’s and Nagelkerke’s R2 are presented as estimates of the proportion of 
variance in the outcome explained by the logistic regression model. 
Receiver operating characteristics (ROC) curves were constructed in studies I–IV. The ROC 
curve is a graphical plot illustrating the diagnostic ability of a binary classifier system (e.g. 
high risk/low risk) as its detection threshold (e.g. chosen cut-off on a rating scale) is varied. It 
is created by plotting the true positive rate (see below) against the false positive rate at 
various threshold settings. The area under the curve (AUC) represents the probability that the 
test will correctly identify two randomly drawn subjects with and without the outcome of 
interest. An appropriate cut-off level can be determined from the ROC curve. One way is to 
choose the level that maximizes the sum of sensitivity and specificity, another is to choose a 
level that is appropriate in a certain context. This in turn depends on the outcome being 
predicted, and the measures taken based on the test result.  
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Accuracy statistics – sensitivity, specificity, positive and negative predictive value – were 
calculated in all studies.  
 True condition 
positive 
True condition 
negative 
Total  
Test positive a b a + b 
Positive predictive 
value: a/(a + b) 
Test negative c d c + d 
Negative predictive 
value: d/(c + d) 
Total a + c b + d  
 Sensitivity 
a/(a + c) 
False positive rate 
b/(b + d) 
False negative rate 
c/(a + c) 
Specificity 
d/(b + d) 
Table 5. A 2x2 table showing how to calculate the accuracy statistics measures.  
 
Sensitivity, true positive rate: the proportion of subjects with the outcome correctly identified 
by the test. 
Specificity, true negative rate: the proportion of subjects without the outcome correctly 
identified by the test.  
Positive predictive value: the proportion of subjects with a positive test result that has the 
outcome. This is dependent on the prevalence of the outcome in the tested population, as is 
the negative predictive value: the proportion of subjects with a negative test result that do 
not have the outcome. 
All tests were two-sided and p-values <0.05 were considered statistically significant. The 
p-value answers the question: if the null hypothesis were true, what is the chance of randomly 
getting the observed result, or a more extreme one? The null hypothesis is usually that there is 
no difference between the studied populations regarding the variables of interest (their 
distribution, correlation etc.). 
Point estimates of AUCs, ORs, accuracy statistics etc. are presented with 95% confidence 
intervals. Provided that our data comes from individuals that were randomly selected from a 
larger population, there is a 95% probability that the interval will contain the point estimate of 
the population from which the individuals were drawn.   
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Rating scales were used to measure factors of presumed interest for the outcome. These 
measurement instruments can themselves be evaluated regarding reliability and validity. 
Reliability refers to the extent to which an instrument gives consistent measures in terms of 
its items measuring the same underlying construct (i.e. the internal consistency of a scale), the 
result being consistent over time (if the phenomenon measured is presumed to be stable) and 
between different users of the instrument. In this project, internal consistency was assessed 
with Cronbach’s α. It has a theoretical range of -∞ to one. Values very close to one indicate 
redundancy; that some items measure the same latent variable. Values below 0.5 indicate that 
more than one underlying construct might be captured by the scale. Interrater reliability was 
assessed with intra-class correlation for the total sums SIS, KIVS and SUAS and with 
prevalence-adjusted, bias-adjusted kappa (PABAK) for the C-SSRS items due to the uneven 
distribution of responses.  
Validity refers to the degree to which a method measure what it claims to measure. The 
instruments evaluated in this project have previously been validated against other 
instruments, and no such evaluations were made with the present data.   
3.4 ETHICAL CONSIDERATIONS 
Given the serious nature of self-harm, it is of importance to study the subject in order to 
provide a scientific basis for future interventions, with the overarching goal of helping those 
afflicted. This project is based on interviews with persons who have recently harmed 
themselves, which called for consideration in all parts of the process: identifying potential 
study participants, giving information about the study and asking for participation and 
administering the research interview. All interviewers collaborated with the regular staff 
members concerning which patients to ask, and when that was appropriate. All patients 
received verbal and written information about the aim and method of the study, the possibility 
to discontinue the interview and to withdraw consent. It was made clear that study 
participation would not affect the treatment. Participants were also informed that the research 
interview was subject to confidentiality unless information of urgent medical character 
transpired, in which case the regular staff would be briefed.  
The interview questions concerned potentially sensitive issues with the possibility of 
triggering strong emotional response from persons already in a vulnerable situation. All 
interviewers had long experience in working with psychiatric patients, and effort was taken to 
create a calm interview setting both in terms of an emotionally safe environment and of 
avoiding external distractions. 
The outcome events were identified via medical records. Since all text was read in order to 
find all mentions of self-harm events, it was inevitable that the persons doing the follow-up 
reading would be aware of a large amount of other data as well. No information apart from 
data on the specified outcomes was registered. In communicating results, it should be kept in 
mind that even though data are presented at group level, some of the groups are very small 
and refer to persons who are still alive or recently deceased, calling for utmost caution in 
presentation of detailed information. 
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3.4.1 Taking part in a study – comments from the participants 
During the planning stage of this study, some members of the hospital staff were concerned 
that the interview would be overly stressful for the participants. This was however not the 
impression of the interviewers – or the hospital staff, once the study was ongoing. Although 
many respondents found it disturbing to relate in detail what they were thinking and feeling 
prior to the self-harm event, most found the research interview a positive experience overall. 
“It was good to talk about it, I haven't described this in so much detail to anyone before”, as 
one of them put it. Many expressed a positive attitude to research being conducted on these 
issues and a hope that others would come to benefit from their participation.  
3.4.2 Interviewing for a study – reflections from a clinician 
Having worked as a doctor for over two decades, I have had many kinds of meetings with 
patients, and I soon realized that the interviews in this project were special. Even though the 
setting was similar to clinical work, the rules were not: the interview was optional, 
participants could say no to begin with or end the interview if and when they wanted, as some 
did. Further, and most important, our meeting was not supposed to end with me deciding 
about something that might be of deep personal importance to the participants, such as being 
kept in hospital or being given – or denied – specific treatment. This situation did of course 
apply to the other interviewers as well and might have contributed to the calm atmosphere of 
many of the interviews. One could in turn speculate as to how this might have affected the 
participants’ introspective abilities and motivation for considering the questions seriously, 
which could affect the external validity of our results.  
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4 RESULTS 
Age, years 33 (23–50)† 
Women 541 (67%) 
Men 263 (33%) 
Suicide attempt at index 666 (83%) 
Non-suicidal self-injury at index 138 (17%) 
Previous suicide attempt  544 (68%) 
Previous non-suicidal self-injury 421 (53%) 
Admitted to hospital bed at index 747 (93%) 
Current occupation  
Work/student/retired 409 (51%) 
Unemployed/sick leave/disability pension 395 (49%) 
Clinical diagnosis at index, any position  
Anxiety disorder (F40–48) 320 (40%) 
Mood disorder (F30–39) 295 (37%) 
Personality disorder (F60) 170 (21%) 
Substance use disorder (F10–19) 172 (21%) 
Disturbance of activity and attention (F90.0) 83 (10%) 
Autism spectrum disorder (F80–89) 54 (6.6%) 
Psychotic disorder (F20–29) 26 (3%) 
Table 6: Baseline characteristics of the sample (N=804) used in Study II and III. 
†median (interquartile range).  
All values except age are presented as N (%). Diagnoses are not mutually exclusive.  
 28 
 Study I Study II Study III Study IV 
N in cohort/in 
analysis 
452/355 804/794-802 804/746 479/422 – 457 
Follow-up time Six months Six months Three months, one year One year 
Outcome 
N (%) 
Non-fatal and 
fatal suicide 
attempt 
78 (22%) 
Non-fatal and fatal 
suicide attempt 
165 (20.5%) 
Three months 
Suicide attempt 
114 (14%) 
Suicide 5 (0.6%) 
One year 
Suicide attempt 
216 (27%) 
Suicide 19 (2.4%) 
Suicide 
14 (2.9%) 
Instrument/s 
evaluated 
KIVS C-SSRS SIS, SUAS, KIVS and 
C-SSRS 
SIS, clinical risk 
assessment 
Main finding KIVS total score 
≥6 is predicts 
suicide attempt 
within 6 months 
SI intensity score 
predicts suicide 
attempt within 6 
months 
SIS score predicts suicide 
at 3 months and one year. 
C-SSRS score predicts 
suicide attempt at 3 
months and one year. 
SUAS & KIVS predicts 
suicide attempt at one 
year. 
The AUC and 
accuracy statistics 
were very similar for 
the clinical 
assessment and SIS 
score.  
OR (95%CI) 
1.81 
(1.08–3.02) 
1.07† 
(1.03–1.1) 
- 
Clinician rated high 
risk 4.1 (1.2–13.4) 
SIS rated high risk  
5.1 (1.5–16.8) 
ROC curve, 
AUC (95%CI) 
 
0.57  
(Not reported) 
0.62  
(0.57–0.66) 
SIS, suicide one year 
0.74 (0.61 – 0.87) 
Clinician 
0.68 (0.53–0.82) 
SIS 
0.72 (0.54–0.89) 
Accuracy 
statistics 
KIVS score ≥6 
Sensitivity 62% 
Specificity 53% 
SI intensity score 
≥18.5 
Sensitivity 59% 
Specificity 57% 
No cut-off for any 
instrument had a 
combined 
sensitivity/specificity of 
at least 80% / 50% 
Clinician 
sensitivity/specificity 
71.4% / 62.3% 
SIS 
sensitivity/specificity 
69.2% / 55.2%. 
Table 7. Main findings of all studies. 
OR=odds ratio. CI=confidence interval. ROC=receiver operating characteristic. AUC=area under the curve.  
†per one-step increment on a 25-point score. 
 
  29 
4.1 STUDY I: INTERPERSONAL VIOLENCE AS PREDICTOR OF SUICIDE 
ATTEMPT  
This study was performed when six-month follow-up was completed for the 452 participants 
included during the first two years, examining the 355 participants with suicide attempt at 
index and complete KIVS ratings. The mean age was 40 years, 63% were women and the 
mean KIVS rating was six with no gender differences. During follow-up, 78 persons (22.0%) 
made a non-fatal or fatal suicide attempt and five of these were suicides. 
A KIVS score of six or more was significantly associated with repetition of suicide attempt 
within six months, with an odds ratio (OR) of 1.81 (95% CI 1.08–3.02).  
As secondary outcome, suicide attempt with use of violent method (here defined as cutting, 
hanging, gunshot, and jumping from height or in front of vehicle in motion) was studied. Of 
the 78 persons with a repeat non-fatal or fatal suicide attempt, 21 (whereof 16 (73%) women) 
used a violent method. Having a KIVS score ≥6 was associated with a violent repeat attempt 
with an OR of 3.4 (95% CI 1.2–9.5). 
4.2 STUDY II: SUICIDAL IDEATION AND BEHAVIOUR AS PREDICTOR OF 
SUICIDE ATTEMPT 
Study II is based on six-month follow-up data from the 804 participants included from 
2012 to 2016. The median age was 33 years, 67% were women and 83% had made a suicide 
attempt at index. During follow-up, 165 (20.5%) persons made a non-fatal or fatal suicide 
attempt. There was no significant difference in prevalence of the outcome related to type of 
self-harm at index, i.e. repeat attempt was as common in the NSSI group as in the suicide 
attempt group. 
The ratings on the C-SSRS item most severe ideation was high and uniform in the sample 
and did not predict the outcome after adjustment. The C-SSRS total score, intensity score and 
separate intensity items frequency, duration, controllability and deterring factors were all 
significantly associated with a repeat attempt during follow-up with ORs of 1.07 to 1.2. The 
area under the ROC curve for SI intensity was 0.62 (95% CI 0.57–0.67) and a SI intensity 
score ≥18.5 predicted the outcome with a sensitivity of 59% and a specificity of 57%. 
4.3 STUDY III: COMPARISON OF PREDICTIVE ACCURACY OF 
STANDARDISED INSTRUMENTS 
This study is based on the same cohort as Study II and was performed when the one-year 
follow-up was complete. Analyses were also made for the three-month follow-up to assess 
the predictive abilities of the instruments KIVS, SIS, SUAS and C-SSRS in this shorter time 
frame.  
During the first three months after the index attempt, 114 persons (14%) made a suicide 
attempt and 5 (0.6%) died by suicide. In total, 216 persons (27%) made a suicide attempt 
during the one-year follow-up and 19 (2.4%) died by suicide. Figure 4 shows the AUC of all 
instruments in predicting suicide attempt at one year follow-up, Figure 5 shows the results for 
predicting suicide during the same time. SIS was the only instrument that could predict 
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suicide during both the 3 month and one year follow-up. KIVS, SUAS and C-SSRS could 
predict suicide attempt during one-year follow-up. 
 
 
 
4.4 STUDY IV: CLINICAL SUICIDE RISK ASSESSMENT VS SUICIDE INTENT 
SCALE  
This study is based on the participants in the Stockholm subset of the cohort described above, 
479 persons with a median age of 33 years. Of these, 69% were women and 81% had made 
suicide attempt at index. The clinical suicide risk assessed by the physician at the emergency 
department and the total score of SIS from the research interview were compared as 
predictors of the 14 suicides (10 men [6.7% of all men], 4 women [1.2% of all women]) that 
occurred during the one-year follow-up.  
ROC curves were constructed and the AUC for the clinical assessment was 
Figure 4. AUCs for the total sum of 
instruments predicting suicide attempt 
within one year of a self-harm event. 
Point estimates of AUCs with 95% CI:  
SIS: 0.47 (0.43–0.52)  
SUAS: 0.60 (0.56–0.65)  
KIVS: 0.56 (0.51–0.60)  
C-SSRS: 0.64 (0.60–0.69) 
Figure 5. AUCs for the total sum of 
instruments predicting suicide within one 
year of a self-harm event. 
Point estimates of AUCs with 95% CI:  
SIS: 0.74 (0.61–0.87)  
SUAS: 0.47 (0.33–0.60)  
KIVS: 0.40 (0.29–0.53)  
C-SSRS: 0.59 (0.47–0.71) 
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0.68 (95% CI 0.53–0.82). The AUC for SIS was 0.72 (95% CI 0.54–0.89). The optimal 
cut-off for the clinical assessment was ≥3 (i.e. high or very high risk), giving a 
sensitivity/specificity of 71.4%/62.3% and a PPV of 6.1%. Corresponding figures for the 
optimal SIS score in this sample (≥18) was 69.2%/55.2%, with a PPV of 6.2%. Defining high 
risk as having been identified by either one of the assessment methods, sensitivity was 85.7% 
and specificity 43.8%. The PPV was 4.8% and the false negative rate (the proportion of 
suicide decedents not identified as having a high risk) was 2/14 (14.3%). If high risk instead 
was defined as being identified on both assessments, specificity increased to 87.5% combined 
with a sensitivity of 53.8%. The PPV was 11.5%, and the false negative rate was 6/13 
(46.2%). Odds ratios of the different high-risk classifications ranged from  
4.1 (95% CI 1.3–13.4) to 8.2 (95% CI 2.6–25.2).  
4.5 INTERNAL CONSISTENCY AND INTERRATER RELIABILITY 
Table 6 shows the estimates of internal consistency and interrater reliability for the evaluated 
instruments. Cronbach’s α reflects the degree to which the items of a scale measure the same 
phenomenon. Values below 0.7 indicate a limited internal consistency. The intra-class 
correlation coefficient and PABAK measures the extent to which the ratings of two 
independent raters correlate with each other.  
 SIS SUAS KIVS C-SSRS 
Internal consistency     
Cronbach α 0.78 0.87 0.64 0.55† 
Interrater reliability‡     
Intra-class correlation 
coefficient; 95% CI 
0.94 
0.85–0.9 
0.99 
0.97–1.00 
0.92 
0.82–0.97 
- 
PABAK - - - 0.63–0.95 for SI 
0.70–0.90 for SB 
Table 6. Internal consistency and interrater reliability of the instruments tested 
†for items CS1–5b, CS7 -11b, Cs12b, 14b, 15b, 17b, and 19b. 
‡based on 20 interviews with two raters making separate assessments. 
PABAK=prevalence-adjusted, bias-adjusted kappa. SI=suicidal ideation items. SB=suicidal 
behavioural items. 
.
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5 DISCUSSION 
In this project, we assessed the role of standardised instruments in predicting suicide attempt 
and suicide in persons already known to have an increased risk of these outcomes. All results 
point in the same direction: yes, there are statistically significant differences in risk correlated 
to the factors measured, and no, these differences are not large or specific enough to guide 
clinical management of an individual patient. The difficulties in predicting an event with a 
low base rate cannot be overcome using the instruments tested.  
5.1 METHODOLOGICAL CONSIDERATIONS 
5.1.1 Population and study sample 
The population in this project consist of patients who, in connection with a self-harm event, 
sought or were referred to psychiatric assessment at a psychiatric emergency department, in 
psychiatric in-patient care or in a medical emergency department. The sampling frame 
consists of individuals from this population who were available in terms of 1: being on the 
premises when research staff was present, 2: speaking Swedish, 3: being able to participate in 
an interview lasting about 1.5 hours, 4: being able to understand the information given and 
give an informed consent.  
Regarding the first criterion, research staff was not on duty every day during the inclusion 
period (April, 2012 to April, 2016). However, all kinds of days (weekdays, weekends and 
holidays such as Christmas and Midsummer) were covered. The research staff had a close 
collaboration with the regular staff, to get information about potential study participants at the 
psychiatric emergency department or patients who had recently been admitted to hospital 
wards. Patients who were discharged or transferred to another clinic directly after assessment 
at the emergency ward were less likely to be available for study participation. This means that 
the study sample probably includes persons with more pronounced psychiatric illness, higher 
perceived suicide risk and/or medically more severe self-harm than the population at large. 
Thus, the results are not generalizable to all persons who self-harm. It is also possible that the 
study sample has been given more extensive treatment and, at least initially after the 
self-harm event, had fewer opportunities for repetition. This could lessen the impact of the 
studied risk factors on the outcomes of interest. 
Regarding criteria 2–4, these excluded non-Swedish speaking patients as use of an interpreter 
was not feasible within the study. The proportion of study participants born outside Sweden 
was 13.4% (95% CI 11.2–16%); the proportion of Swedish residents born in another country 
was 15.4% to 17.9% during the inclusion period (150). Even though the proportions are quite 
similar, the language criterion implies that the results might not be applicable to persons from 
all cultural backgrounds. Criteria 2–4 also excluded patients with symptoms interfering with 
verbal communication e.g. intoxication, confusion, severe psychotic symptoms and 
aggressiveness. If the patient was admitted to hospital and these symptoms abated within a 
few days, they were eligible for inclusion, but it is still possible that the results from this 
project cannot be generalised to all diagnostic categories.   
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5.1.1.1 Completeness of data 
The participants were free to abort the interview, and not all rating scales were completed by 
all participants. There was no significant differences regarding age, sex, type of index attempt 
or prevalence of either outcome between participants with and without complete ratings (see 
supplementary Table 1, Study III).  
5.1.2 Identifying the outcome  
Information on suicide attempts during follow-up was gathered from the medical record 
which likely minimised loss to follow-up as the participants did not have to be contacted 
again for a new interview. Even though the medical record systems used at the three sites do 
not have complete coverage of all potential caregivers (e.g. of all medical emergency 
departments, all primary care and psychiatric outpatient settings), one-year follow-up data 
was available for 775 participants (96%). 
In Study I and II, we used medical record data for all outcome events. In the analyses, only 
events clearly described as suicide attempts or suicides were included. This could imply a risk 
of underestimating the incidence of both repeat suicide attempt and suicide. However, the 
non-fatal repetition rate is similar to that of other cohorts where the patient report is used to 
identify this outcome (29). Two non-systematic observations from reading 422 of the medical 
records were that many self-harm events are not registered with an ICD-10 diagnosis, merely 
noted in plain text, and some self-harm events are registered with an ICD-10 diagnosis 
several times, on different dates. This does not affect the studies in the present project but 
could be worth to bear in mind when relying on register data alone for non-fatal self-harm 
outcomes. 
When register data was obtained from the National Cause of Death register, the deaths caused 
by events of undetermined intent were included in the outcome suicide to avoid 
underestimation of the suicide risk, in line with previous research. There is of course a 
possibility that some of these events were accidents, in which case the suicide risk is 
overestimated in Study III and IV. The one-year suicide rates were 2.4% in Study III and 
2.9% in Study IV. If the events of undetermined intent are excluded, the one-year fatal 
repetition rate is 1.9% in Study III and 2% in Study IV. 
In the systematic review by Owens from 2002, the median one-year suicide rate was 1.6% 
with an interquartile range of the point estimates from the individual studies of 0.8–2.6% 
(28). In the systematic review by Carroll from 2014, the one-year fatal repetition rate based 
on all studies reviewed was 1.6% (95% CI 1.2–2.1) (29). A higher fatal repetition rate was 
found in samples with an above-average proportion of men, in older samples and in samples 
with below-median proportion of poisoning used at the index episode. The proportion of male 
participants in Study III and IV was 33%; below the average reported by Carroll, and the 
median age is 33 years, almost identical to the one reported. However, the proportion of 
participants using poisoning at the index self-harm event was lower in our sample; 63% 
compared to the median of 90%. For this group, the fatal repetition rate reported in the 
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systematic review was 2% (95% CI 1.2–3.2%). It is known from previous studies that method 
of non-fatal self-harm has an impact on future suicide risk (65), and it is possible that the 
relatively high suicide rate seen in the present studies is explained by this factor. 
5.1.3 General considerations 
In Study I, only participants with a suicide attempt at index were included, to keep this study 
as similar and comparable to the original KIVS study as possible. During the inclusion period 
following the first study, and when analysing the complete data set, it was noted that many 
participants reported mixed intentions, sometimes changing the self-reported level of suicidal 
intent from the first contact with a health care professional to the research interview. This can 
be interpreted in different ways: the patient can be seen as lying or manipulating, telling the 
story that fits best at a specific moment, or it can be seen as a reflection of how difficult it is 
to know the true intention of our actions, if there is such a thing. It was also noted that a large 
proportion (68%) of participants with a non-suicidal index event had made previous suicide 
attempts, and that there were no significant differences regarding outcome (neither suicide 
attempt nor suicide) between the groups. In study II–IV all participants were included 
regardless of index type of self-harm.  
5.2 INTERPERSONAL VIOLENCE ASSESSED WITH THE KIVS 
Interpersonal violence measured with the KIVS was found to be associated with an increased 
risk of subsequent suicide attempt within six months (Study I) and one year (Study III). It was 
not correlated to suicide in the one-year follow-up, in contrast to the findings in a previous 
study where the predictive ability of KIVS was assessed against five suicides during a four-
year follow-up, and exposure to violence in childhood and expression of violence as an adult 
was associated with an increased risk of suicide (132).  
The KIVS total score was marginally better than chance in predicting the composite outcome 
non-fatal and fatal suicide attempt at six months with an AUC of 0.57. In predicting non-fatal 
suicide attempt within one year, the AUC was 0.56. Sensitivity and specificity were poor, and 
even the negative predictive value (the proportion of participants classified as low risk, who 
did not make a suicide attempt during follow-up) of 77% was low compared to the other 
instruments assessed in Study III. These results indicate that experience of interpersonal 
violence assessed with the KIVS cannot on its own be used as a clinically meaningful 
predictor of repetition within six months or one year. An evaluation of the secondary outcome 
repeat suicide attempt with a violent method in Study I found that a KIVS score ≥6 predicted 
this outcome with an OR of 3.4. If this correlation was evaluated in women only the OR was 
almost five with quite a wide confidence interval of 1.32–17.26. This might indicate that the 
KIVS score is more strongly correlated with violent reattempts, and that women are more 
vulnerable to this effect, but if thought to be of interest, this should be studied as a primary 
outcome measure in a larger cohort.  
The interpersonal-psychological theory posits that a suicide can only occur if there is a desire 
to die and a capability for suicide (103). It is not clearly stated but reasonable to assume that, 
once acquired, the capability remains fairly stable and it is by variation of the desire to die 
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that suicide risk can be modified. It has been suggested that experience of interpersonal 
violence increases the suicide risk via an increased risk for depression and substance abuse 
(151, 152). A majority of the study participants were admitted to hospital at the index attempt 
and later discharged to outpatient treatment. It is possible that the factors influencing the 
desire to die (or to use the framework of the integrated motivational-volitional model: keeps 
the motivational phase active) are addressed in treatment, lessening the connection between 
the experiences measured by the KIVS and the outcome. Interpersonal violence is associated 
with an increased suicide risk in a life-time perspective (54, 153), but it seems to be of little 
relevance in prediction of one-year fatal repetition.  
This aside, the instrument could still be of use. The negative health effects of exposure to and 
expression of interpersonal violence are well documented, as is the low level of exploration 
of these issues in Swedish health care settings (154). A short structured instrument could 
make it easier to ask these sensitive questions and take the answers into consideration in 
treatment planning and/or referral to other facilities (e.g. social services and special projects 
for those who harm others).  
5.3 SUICIDAL IDEATION AND BEHAVIOURS ASSESSED WITH THE C-SSRS 
Suicidal ideation (SI) and behaviours assessed with the C-SSRS were used as predictors on 
non-fatal and fatal suicide attempt in Study II and as predictors of suicide attempt and suicide 
as separate outcomes in Study III. 
In Study II, the total C-SSRS score and the SI intensity score were associated with non-fatal 
and fatal suicide attempt within six months of the index event. SI severity was not associated 
with this outcome after adjustment for other risk factors, which is likely due to the fact that a 
majority of participants reported very severe suicidal ideation, and where there is little or no 
variation in the rating, there can be no separation of sub-groups. The adjusted OR for the SI 
intensity score was 1.07, which means that for each one-step increment in score, the odds of 
the outcome increase by 7%. If this score changes from 5 to 15, the odds of the outcome 
increases by 97% (1.0710=1.97); a change from 5 to 25 increase it by almost four times 
(1.0720=3.87). The AUCs for the total score and the SI intensity score showed that they were 
marginally better than chance in classifying the outcome correctly, and it was not possible to 
find a cut-off that yielded acceptable combinations of sensitivity and specificity for the rating 
scale to be of clinical use in predicting suicide attempt on an individual level.  
Similar results were found in Study III where the total score was used as predictor. There was 
no correlation between the C-SSRS total score and suicide during follow-up, and results 
similar to those of Study II in predicting suicide attempt. Suicide has not previously been 
evaluated as an outcome in prediction studies employing the C-SSRS, so no comparisons can 
be made.  
Most previous prediction studies using the C-SSRS have not been focused on repetition of 
self-harm. One exception is the study by Posner and co-workers, on 124 adolescents with an 
actual or interrupted suicide attempt within 90 days of inclusion, where lifetime worst-point 
SI severity predicted suicidal behaviour (actual, aborted and interrupted suicide attempts and 
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preparations) within a six month follow-up (13). SI intensity was not studied as a predictor in 
this cohort. The proportion of actual suicide attempt at baseline was low in this sample, 13%, 
and in such a context severe SI could serve as a risk factor. This could also explain the strong 
correlations between SI severity and future suicidal behaviours (SBs) observed in a 
meta-analysis of clinical trials where C-SSRS was used to detect treatment-emergent 
suicidality (155). Less than 5% of all study participants endorsed ever having suicidal 
ideation with some intent and plan, and this was associated with an OR for future SBs of 18.7 
and 78.6 in the psychiatric and non-psychiatric populations, respectively.  
The findings in Study II and III on SI intensity and the C-SSRS total score are in line with 
previous research. SI intensity has been associated with an increased risk of suicide attempt in 
adolescents and young adults seeking psychiatric emergency treatment (140, 141) and the 
intensity item deterrents was associated with suicide attempt during a short-time follow-up in 
adolescents with previous suicidal behaviour (142). The total sum of C-SSRS was predictive 
of suicidal behaviours within six months in an adult psychiatric inpatient cohort (143), 
however neither the prevalence of previous self-harm nor the proportion of actual suicide 
attempts during follow-up was reported, making comparisons with results from Study II 
difficult. 
Even though the C-SSRS total score or subscales cannot predict suicide and are only 
modestly correlated to non-fatal repetition, the instrument could be of use in structuring the 
patient report and using defined terms for different suicidal behaviours. Some aspects of its 
psychometric properties could however be discussed:  
The C-SSRS is presented as assessing four constructs: suicidal ideation severity, suicidal 
ideation intensity, suicidal behaviours and actual or potential medical severity of previous 
attempts (13). This is stated in the study introducing the scale, with limited theoretical backup 
and no factor analysis. A later study of the underlying structure of the English version in an 
adult psychiatric inpatient sample found support for a two-factor solution, with severity of 
ideation and behaviours loading on one factor and intensity of ideation on the other (143). In 
an adolescent outpatient sample, testing the Turkish version, a three-factor solution fitted the 
data better (156). Experiences from the current project were that the SI severity items were 
fairly easy to understand and score, (e.g. have you in the past 30 days had the thought that 
you would be better off dead, yes/no?) as were the behavioural items. This was reflected in 
robust measures of interrater reliability for the behavioural items with prevalence-adjusted, 
bias-adjusted kappa (PABAK) between 0.70 and 0.90. Regarding the internal consistency, 
Cronbach’s α for the five items assessing SI severity was 0.64 whereas the PABAK for the 
single item most severe ideation, which sums up SI severity, was 0.95.  
Cronbach’s α for the SI intensity subscale was 0.49 which could indicate that this subscale 
measures more than one underlying construct, similar to the findings in a validation study on 
the Spanish version of the C-SSRS in an adult psychiatric outpatient sample (157). These 
items were sometimes challenging to assess properly. Many respondents reported both 
maximum frequency and maximum duration of suicidal thoughts, i.e. thoughts appear many 
times each day, and last at least 8 hours or are persistent. This can be true if “many times” is 
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not more than three times, otherwise it does not work out. The responses to the item 
deterrents also needed consideration. Some participants who had just made a suicide attempt 
initially stated that they would never attempt suicide because of their children or religious 
beliefs. This might have been their sentiment during the interview, but considering the very 
recent suicide attempt it clearly had not been the case during the whole past month. This item, 
which also has a slightly confusing response alternative (0=does not apply) had the lowest 
PABAK, 0.63 compared to 0.89–0.92 for the other SI intensity items.  
It might seem petty to point out these inconsistencies, but if these aspects are important to 
measure, it would be important to measure them correctly. The instructions in the C-SSRS 
are not always clear and can be misunderstood, as has previously been pointed out (14). An 
evaluation of the psychometric properties of the instrument noted that more research was 
needed to assess if the more granular C-SSRS categories were motivated (16). The 
assessment of convergent and divergent validity (the extent to which test result correlate to 
another test said to measure the same construct, and the extent to which it does not correlate 
to a test that measure something supposed to be completely different) has mainly been 
assessed in adolescent and adult populations with mood disorders (13, 143, 156, 157) and it is 
not evident that these results can be transferred to children, older adults, or to all diagnostic 
categories (e.g. psychosis, autism, intellectual disability or mild cognitive impairment) (158).  
5.4 COMPARISON OF THE RATING SCALES 
When the SIS, SUAS, KIVS and C-SSRS were compared as predictors of suicide attempt and 
suicide as separate outcomes, the main findings were that the SIS was the only instrument 
reasonably able to predict suicides whereas the other rating scale could predict suicide 
attempt within a year of the index event, and that the SIS and the C-SSRS could predict 
suicide and suicide attempt respectively also at a three month follow-up. The overall 
predictive accuracy of all the tested instruments was limited.  
The findings for SIS are in line with most but not all previous studies, where positive results 
have been reported from larger samples with long follow-up times (148, 159). In comparison, 
Study III is one of the largest, with among the shortest follow-up times. The predictive 
accuracy was evaluated for the first three months of follow-up with partly excellent results; 
an AUC of 0.94 and sensitivity/specificity of 100%/81.9% for a total score ≥21. The PPV 
was 2.8%. Since the results were based on a very small number of suicides (n=4) the 
implications of this result should not be exaggerated.  
The results for the KIVS are discussed in section 5.2. Concerning SUAS, Niméus and co-
workers found the total score to be predictive of fatal repetition within a year in a cohort of 
suicide attempters (145), but this could not be replicated in the present sample. The cohorts 
likely represent somewhat different populations as all participants in the Niméus cohort had 
been treated in a medical intensive care unit after a suicide attempt and then transferred to a 
suicide research ward where they were asked to participate in the study after about a week. 
There was also a higher one-year suicide rate, 4.2% compared to 2.4% in this sample.  
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The C-SSRS did not predict suicides. In a recent meta-analysis of 71 studies evaluating 
suicidal ideation as predictor of suicide over a mean follow-up time of 9 years, the pooled 
odds ratio of suicide associated with suicidal ideation was 3.4, with sensitivity/specificity of 
46%/81% in psychiatric samples (160). In studies with a high proportion of patients with 
suicidal ideation and in hospital-treated samples the specificity was lower. Similar results 
were found in a meta-analysis of suicidal ideation and behaviours as risk factors for both 
suicide attempt and suicide over a mean follow-up time of 4 years (161).  
5.5 THE CLINICAL SUICIDE RISK ASSESSMENT AND SIS 
The results in predicting suicide within one year of the index self-harm event were very 
similar for the Suicide Intent Scale and the clinical risk assessment. The sensitivity, 
specificity and positive predictive value were limited for both methods. These estimates 
changed in a predictable way if high-risk status was made easier (identified by either method 
yielded increased sensitivity) or more difficult (identified by both methods increased 
specificity) to obtain. The pre-specified cut-off for SIS resulted in non-significant results and 
it should be noted that all significant results were based on optimal performance of the 
respective assessment methods in this specific sample, and might not be generalizable to 
other samples. These results do not support that a standardised instrument such as SIS has 
better predictive properties than the clinical risk assessment. There are no previous studies 
comparing the clinical risk assessment to the SIS, or any other structured instrument with 
suicide as an outcome. Previous studies comparing rating scales to the clinical risk 
assessment regarding non-fatal self-harm have come to different conclusions. In one study, 
the clinical global evaluation was compared to the Manchester Self-Harm Rule (MSHR), and 
the authors suggested prioritising the high sensitivity of the MSHR over the clinical risk 
assessment which had a higher specificity (162). This study was performed in non-psychiatric 
emergency settings, where the decision to be made was if the patient should be referred to a 
specialist assessment or sent home. In such a context, a high sensitivity and a large proportion 
of false positives is not only acceptable but also preferable. At a psychiatric emergency 
department however, which would be the recipient of these referred patients, it is neither 
feasible nor desirable to admit everyone with high risk according to some highly sensitive but 
unspecific risk scale.  
In another study, the predictive performance of the clinician was compared to that of the 
patient and the SAD PERSONS scale, the Barratt Impulsiveness Scale and the MSHR in a 
sample of persons who had been referred to liaison psychiatric services after self-harm. None 
of the risk scales performed better than the clinician or the patient in predicting repeat self-
harm within six months, and the authors concluded that the use of risk scales might be a 
waste of resources (163). This was questioned by Fazel and Wolf, who pointed out that 
another way of describing the results, which also applies to the present study, is that the 
clinician is not better than the risk scales and that the transparency and reliability of the risk 
scales are important advantages (164).  
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5.6 WHY IS IT SO DIFFICULT TO PREDICT SUICIDE ATTEMPT AND SUICIDE? 
Suicides are tragic. This unfortunately has no impact on their predictability. Infrequent and 
multifactorial events will always be more difficult to predict than frequent, well-understood 
events. 
5.6.1 A suicidal act is the result of a temporary state of mind 
The above quote from Merete Nordentoft (165) signals an important aspect: even though 
there can be a suicidal process where ideation precedes preparations which precede action, 
the act can be triggered suddenly, by factors unknown to the patient or the clinician at the 
time of assessment. The time from onset of thinking about attempting suicide to initiation of 
an attempt was explored in a sample of suicide attempters where 48% reported that this time 
span was less than ten minutes (166). Less than five minutes from decision to action was 
reported by almost a quarter of survivors of near-lethal attempts (167). This indicates that at 
least for some persons attempting suicide, there might be very limited possibilities for other 
people to intervene.  
Suicide risk assessment – by use of structured instruments or a clinical interview – consists of 
gathering information present at the time of assessment. The idea of assessing suicide risk in 
this manner rests on the underlying assumption that lack of knowledge is the source of 
uncertainty regarding suicide risk, and the more that is known about the patient’s present 
status, the more accurately suicide risk will be assessed and managed. There are however 
chance factors that will influence the suicide risk – factors that cannot be evaluated since they 
are not present or imaginable at the time of assessment (168). These aspects highlight the 
need of preventive measures on a societal level like raising community awareness, restricting 
means, and eliminating barriers to help (165). 
5.6.2 Suicide is a rare event 
In Sweden, three to four persons die by suicide each day. Table 7 is modified from Galen & 
Gambino’s seminal work from 1975 [Beyond Normality quoted in (169)] and shows the 
positive predictive value (PPV, the proportion of subjects with a positive test result that has 
the outcome) of a hypothetical test, at different base rates and different combinations of 
sensitivity and specificity. At a base rate of 10/100,000 (similar to the annual suicide rate in 
Sweden), a test with 90% sensitivity and 90% specificity will have a PPV very close to zero. 
None of the instruments in this project (with the possible exception of SIS predicting suicide 
at three months follow-up), or in any of the studies referenced have similar accuracy 
statistics. 
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 Sensitivity, % 
Specificity, % 50 70 90 95 99 
 Base rate 10/100,000 – about the annual suicide rate in Sweden. 
50 0 0 0 0 0 
70 0 0 0 0 0 
90 0 0 0 0 0 
99 0 1 1 1 1 
 
Base rate 500/100,000. A previous suicide attempt is suggested to increase 
the risk 50–100 times, i.e. at least to this base rate. 
50 1 1 1 1 1 
70 1 1 1 2 2 
90 2 3 4 5 5 
99 20 26 30 32 33 
Table 7. The PPV in percent at different base rates and different combinations of sensitivity 
and specificity. Adapted from Galen & Gambino. 
 
In this project, the one-year incidence of suicide after self-harm was 2.4% which corresponds 
to a suicide rate of 2,400 suicides/100,000 persons and year. At this base rate, and with a SIS 
total score cut-off chosen to maximise both sensitivity and specificity, the positive predictive 
value was 3.9% (see Table 2, Study III). This means that in this sample of patients with a 
high one-year suicide risk, high-risk classification according to the only instrument where 
there was a correlation between total score and future suicide, was correct in only 3.9% of the 
cases.  
Another example can be drawn from a systematic review and meta-analysis on prospective 
controlled studies on clinical factors associated with in-patient suicide. The authors found a 
strong correlation between high-risk status (categorised on the basis of multiple risk factors 
e.g. a psychotic disorder, prior self-harm, depressed mood, anxiety) with an OR of 10.9, and 
pooled estimates of sensitivity/specificity of 64%/85% (72). In spite of the large OR and fair 
accuracy statistics, the positive predictive value of the high-risk categorisation was only 1.4% 
because of the low base rate of in-patient suicides. 
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5.6.3 The problem with a low PPV 
“It is ironic that if we had a perfect predictive instrument we would not be able to 
 recognize it because it could never be validated by its critical outcome criterion.” 
  Jerome A. Motto, 1991 (170). 
A low PPV becomes a problem if someone is expected to act on the result of the test. What 
actions can be motivated if only a small minority of those identified by the test will actually 
have the outcome? All interventions carry a cost, in monetary terms as well as time and 
commitment, and not all interventions are desired by the person at risk.  
A related problem concerns those not identified by the test as having a high risk. Depending 
on how high-risk status was defined in Study IV, two to six persons who died by suicide were 
classified as having a low risk, i.e. the false negative rate varied from 14.3% to 46.2%. This 
inherent problem of categorization based on risk assessment has been described by Large and 
co-workers, emphasising that the low-risk group often is so large that a small proportion of it 
contains more persons than the larger proportion of the smaller high-risk group – thus most 
suicides will occur in the low-risk group (72, 171). This implies that suicide rates might not 
be much affected by reserving some interventions for those with high scores on a rating scale. 
In this context, it is also worth bearing in mind that a large proportion, 50–68%, of all first 
attempts result in death (172-174). Seeing as a previous attempt is considered to be the major 
risk factor for suicide, these persons might have had small chances of receiving a high-risk 
classification. 
The low PPVs found in this kind of studies are particularly troublesome. A low PPV in a test 
for something that either is or isn’t prevalent at the time of the test is problematic for the 
reasons given above. But all the PPVs reported here and in most studies on suicide prediction 
represent the proportion of high-risk individuals who will have the outcome in spite of this 
identification and in spite of the treatment given. In the larger sample used in Study II and III, 
93% of participants were admitted. Treatment data was not registered, but the impression 
after completing the follow-up was that the vast majority at least in the Stockholm subset had 
pharmacological treatment, that virtually all who had been inpatients were offered outpatient 
treatment, not only for follow-up prescription of medicine but most often with some 
psychotherapeutic or otherwise supportive contact. Care plans and safety strategies were 
often discussed. It follows that there might be very little room for improvement on the rates 
of suicide attempt and suicide in this group were the studied instruments included in clinical 
routines. 
5.6.4 The low predictive accuracy of the major risk factors 
Sometimes terminology clouds the mind. The major risk factors, like previous self-harm in 
combination with psychiatric diagnosis, are not major in a way that is helpful to prediction in 
the individual case. 
A factor can be of major etiological importance without being helpful in prediction just as a 
factor with good predictive properties can be unrelated to the causal mechanism of the 
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outcome. A factor that is present in some group members and associated with a two to 
fivefold increase in the risk of a specific outcome cannot discriminate between groups that 
will and will not have that outcome (48). Even a factor that increases the risk of an outcome 
by 200 times cannot completely discriminate between groups (175). Most risk increases 
observed in this project are much smaller than this: in Study I, ORs of 1.81–3.2 were seen, in 
Study II the largest possible increase in odds was about 25 times (the OR was 1.08 for the 
total score, which has a range of 0–42) and in Study IV the ORs ranged from 4.1 to 8.2.  
In a meta-analysis from 2017, the authors examined 365 longitudinal studies on prediction of 
suicidal ideation and behaviour published over the past 50 years, with a total of 3,428 risk 
factor effect sizes. Weighted mean odds ratios and accuracy statistics (AUC, sensitivity, 
specificity) were calculated for all studies and for separate categories of risk factors 
(biological, demographic, psychopathology, personality traits, psychosis, prior self-harm 
etc.). The weighted mean odds ratio for prediction of suicide attempt was 1.51, and the 
corresponding figure for suicide was1.50. The diagnostic accuracy was poor for both 
outcomes with weighted mean AUCs of 0.58 and 0.57 respectively (47). Similar findings 
were observed in the separate meta-analysis of suicidal ideation and behaviour as predictors 
for suicide attempt and suicide: the weighted mean odds ratio was 2.16 for prediction of 
suicide attempt and 1.54 for suicide. For both outcomes, there was evidence of publication 
bias and when this was accounted for, ORs were reduced to 1.68 and 1.51 (161).  
5.6.5 The low predictive accuracy of many risk factors in combination 
In 1983, Alex Pokorny published a paper describing his attempts to predict suicide in a cohort 
of 4,800 psychiatric inpatients. Data collection was thorough with use of many diagnostic and 
other rating instruments available at the time, including structured observation by the ward 
nurses and an interview with a research social worker. With about 100 items per patient to 
evaluate, it was not possible to find a set of items that in a clinically meaningful way could 
identify the patients who later died by suicide. Pokorny concluded:  
“The negative findings of this study have clear implications. The court and public opinion 
seem to expect physicians to be able to pick out the particular persons who will later commit 
suicide. Although we may reconstruct causal chains and motives after the fact, we do not 
possess the tools to predict particular suicides before the fact” (169). 
He reanalysed the data a decade later, using logistic regression instead of discriminant 
analysis, with the same results (176). In the validation study of the suicide risk estimator 
published by Motto in 1985 (118) and mentioned in section 1.5, it was not possible to 
replicate the original findings. The author concluded: 
“Suicide may be a behavioural outcome reached by so many different pathways that no 
constant set of clinical features can serve as an accurate prediction equation. […] Our 
findings highlight the likelihood that suicide scales derived by multivariate analysis of a large 
number of […] variables may tend to be arbitrary and sample specific” (177). 
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5.6.6 Barriers to perfect clinical predictions 
Clinicians make lots of assessments and predictions, but there are few if any formalised tests 
of their accuracy. The only way to improve one’s predictive accuracy is to make many 
predictions which are precisely defined regarding the outcome, the time frame and the 
estimated probability in numerical terms, to get feedback on every prediction on the basis of 
which one adjusts one’s future predictions (178). This might be challenging when it comes to 
suicide. Being precise would require a statement like “I estimate that this person has a 3% 
probability of dying by suicide within the coming year” and although the outcome and 
timeframe can be formulated, many feel awkward on having to decide on a numerical value 
(178). This might be overcome, but the main problem lies in the next step: getting feedback. 
Most of the time, the patient will not die, whatever the estimated suicide risk. For the 
clinician, suicides are rare events even in high-risk populations and the possibility of getting 
enough feedback is (thankfully) small. An assessment of increased suicide risk would also 
elicit some intervention to minimise it, and with a successful intervention the probability of a 
correct prediction lessens. Another complicating factor regarding feedback is that suicides are 
not similar – the “feedback” gotten from one will not necessarily help in another case. One 
patient dies by suicide, off medication and in the initial phase of a psychotic relapse, in spite 
of the carefully made safety plan and the well-informed next-of-kin. Another person with a 
similar diagnosis dies to everyone’s bewilderment despite medication adherence, no observed 
symptom recurrence and no signs of stress or worry. What lessons are to be learned from the 
first case that could have prevented the second? 
5.6.7 Big data and machine learning cannot circumvent the low base rate 
A fair amount of hope has been placed into the development of so-called third-generation 
prognostic models. These are proposed to differ from first generation, i.e. clinical assessment 
and second generation, i.e. most risk assessment instruments in that they are composed not 
only of statistically derived static factors but also of dynamic risk factors which could be 
measured in real-time. The latter is made possible with the use of smartphones, frequent 
symptom ratings and continuous access to social media accounts (179, 180).  
This has been explored in several studies using machine learning techniques to extract risk 
factors from large datasets in order to construct mathematical prediction models for suicide 
and suicide attempt. Among other institutions, the US Army has devoted resources to this line 
of research in response to the increasing suicide rate among its soldiers. Using multiple data 
sources and employing advanced statistical methods and machine learning on a sample of 
more than 40,000 soldiers with 68 suicides, the following risk factors were identified: male 
sex, older age at enlistment, weapon ownership, crime perpetration, previous psychiatric 
disorder and previous suicide attempt (181). In this sample, 53% of the suicides occurred in 
the 5% identified as having the highest suicide risk. In another study, the medical records of 
100 suicide decedents and 140 matched controls were analysed with a machine-learning 
system able to recognise patterns associated with a known outcome. This revealed that the 
words agitation, frightened and adequate were particularly common in the records of suicide 
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decedents, whereas neut[rophils], presbyopia and dishevelled were associated with 
psychiatric disorder without suicide. This is not a finding of immediate clinical use. The 
overall accuracy (which in these studies is defined as (sensitivity + specificity)/2) of the 
different models tested was 60–69% (182) which is fairly similar to some of the results in the 
current project (e.g. the accuracy calculated in this way for the clinical risk assessment 
predicting suicide during a one-year follow up was 67%).  
In another recent effort, genetic information from repeated blood samples was combined with 
self-assessment of anxiety and mood to derive a predictive model for increased suicidal 
ideation or hospitalisation due to suicidal ideation (SI) (i.e. less serious outcomes than suicide 
attempt and suicide). Among a very large number of findings, it was found that the genetic 
information alone could not predict increase in SI, that information regarding previous 
suicide attempt and current stress were predictive of this outcome and that the combination of 
genetic and other information might improve prediction of increased SI, in the dataset that 
gave rise to the model (183). Many of the other findings concerned the activation of different 
genes and the possible associations between this and suicidal ideation, which might be 
interesting from an etiological point of view. 
In an ongoing study, the Durkheim Project, a real-time monitoring system is tested in US 
army veterans. Accessing the study participants’ social media accounts and combining their 
online activity with individual history, suicide risk is updated whenever new information 
arises and a risk estimate is delivered to the clinician together with a probability of the risk 
estimate (184). As of yet, it is a non-interventional study and there are no published results.  
Using an approach like this could potentially be highly problematic, not only from an 
integrity perspective but also in terms of transparency of how decisions and assessments are 
made (185). If all suicides are to be prevented with such an approach, everyone will need to 
be monitored. One could also speculate as to what would or should happen if an algorithm 
identifies a suicide risk that is denied by the person in question. Those familiar with the 
Precrime Unit (which, based on the visions of the precognitives, imprisons persons due to 
crimes they are predicted to commit, regardless of what they have done or claim they will do 
next) (186) might be apprehensive of such a scenario.  
In a very recent systematic review of prediction models of suicide and suicide attempt, 
models derived from 2005 and onwards (and including the risk estimator from 1985) were 
tested and simulations of the models’ predictive accuracy were made using large datasets. 
The results presented are strikingly similar to those of Galen & Gambino, Pokorny, Large and 
others, and the authors conclude that also the modern, big-data-derived suicide prediction 
models have a near zero predictive validity (187). 
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5.7 HINDSIGHT BIAS, AND PREDICTION OUTSIDE PSYCHIATRY 
“It’s tough to make predictions, especially about the future.” 
This quote has been attributed to Yogi Berra and others, and at first it might sound like a joke, 
or plain stupidity. But when something has happened it is surprisingly easy to forget that 
there is a difference between (seeming to) understand why it happened and being able to 
foresee it, based on the information present before the event. Hindsight bias, the tendency to 
overestimate the predictability of an event (or one’s own prediction skills), when one knows 
that the event occurred (188), has been studied in different settings and it is a recurrent 
finding that knowledge of the outcome can affect the estimate of the risk and of the 
predictability of the event, as well as the appraisal of the actions taken before the outcome. In 
a recent study, clinicians were asked to rate the quality of care in a retrospective case note 
review, where the alleged outcomes were randomized. The quality of identical care was rated 
as low if the outcome was negative and adequate or good if the outcome was positive (189). 
In another study, knowledge of the fictional outcomes suicide and violent behaviour affected 
the risk estimates in a series of hypothetical cases (190). Evidence suggests that more 
comprehensive knowledge and actual experience of the task to be appraised can lessen the 
impact of hindsight bias (191).  
Predictive accuracy has been studied in many disciplines – the stock market, sports, politics 
and weather just to name a few. To quote the authors of a study evaluating over 6,000 
predictions made by 68 stock market forecasters, a few forecasters are “uncannily accurate”, 
but on the whole the results seem to be close to random (192). Weather forecasting is more 
successful. There is vast knowledge about what causes common weather phenomena and 
there are innumerable weather stations continually measuring data known to be essential for 
weather forecasting. Since there always is weather, there is continuous feedback which makes 
it possible to adjust and perfect the forecasting algorithms. Under these circumstances, and 
with the use of supercomputers, weather can be accurately predicted about 80 percent of the 
time for a seven-day forecast (193). If one wants to predict the weather more than eight days 
ahead, it is better to rely on yearly average than the data present today (194). Even if the input 
data were perfect, and the algorithms flawless, it is not expected that weather predictions will 
ever be completely accurate in a time span longer than 14 days, because of the complex 
interactions between a multitude of factors (195). Not all weather phenomena are equally 
predictable, though. Temperature and precipitation and also more rare events such as 
hurricanes and floods are possible to predict whereas earthquakes still are close to 
unpredictable (194). 
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“The problem of prediction is not unique to suicidal behaviour, rather, it’s the theoretical 
basis for prevention in many disorders where the most successful strategy has been to focus 
on whole-population approaches rather than focusing on individuals at high risk.” 
 Simon Hatcher, The International Handbook of Suicide Prevention, 2016 (115).  
Many medical conditions are better understood in terms of aetiology, natural course and 
treatment response than suicidal behaviour. Yet death is an accepted albeit sad outcome of 
disease. In Sweden, 85 persons die due to cardiovascular disease and 65 persons die of cancer 
each day (41), but it has never been mandatory to report these deaths and scrutinise the 
actions of the treating physicians to assess what kind of mistakes were made that allowed for 
all these people to die. But in the case of suicide, despite vast empirical support of its 
unpredictability in the individual case, there still seems to be a need to hold someone 
responsible for it. This is an intriguing psychological phenomenon far beyond the scope of 
this project.  
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6 CONCLUSIONS AND PRACTICAL IMPLICATIONS 
The standardised instruments studied in this project cannot, in a clinically meaningful way, 
predict suicide attempt or suicide. These findings are in line with the past 50 or so years of 
research, and more studies with a similar approach would not seem to be needed. Regarding 
future directions of research, the more recent suicide prediction approaches with constant 
monitoring not only of symptoms but of people’s social media interactions have ethical issues 
which are not easily resolved. 
The studies presented here do not indicate that all standardised instrument are completely 
useless, as other potential areas of usage have not been examined. Thus, the instruments 
might still be valuable as a way of structuring the clinical assessment, to ensure that 
potentially important experiences are explored or as an aid to monitor change in potentially 
relevant symptoms.  
Neither do the results of these studies indicate that clinical risk assessment should be 
abandoned just because it will not prevent all suicides by way of predicting them. Risks that 
are impossible to assess with precision can still be managed, and persons struggling with 
suicidality will not benefit from clinicians’ dejection and cynicism. The continued sanity and 
optimism of clinicians assessing suicidal patients, on the other hand, would benefit from more 
realistic expectations regarding the prediction and prevention of death, more in line to that 
which is expected of our colleagues in other fields of medicine. I sincerely hope that a more 
balanced view of this will emerge.
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7 SVENSK SAMMANFATTNING 
Syfte 
Avhandlingens syfte har varit att undersöka hur väl suicidförsök och suicid efter självskada 
kan förutsägas med hjälp av fyra skattningsskalor baserade på kända riskfaktorer för dessa 
utfall. 
Metod 
Alla delstudier baseras på en klinisk kohort med patienter som sökt eller hänvisats till en akut 
psykiatrisk bedömning efter en självskada (indexförsöket). Inklusionen ägde rum i 
Stockholm, Göteborg och Umeå under åren 2012 till 2016. Patienterna kunde inkluderas om 
de inom den senaste veckan genomfört en självskada med eller utan suicidal intention. De 
skulle också kunna delta i en ca 1,5 timme lång intervju på svenska för insamling av baseline-
data inklusive skattningsskalorna. För att möjliggöra uppföljning i journal och genom uttag 
från Dödsorsaksregistret skulle deltagarna bo i respektive sjukhus upptagningsområde och ha 
svenskt personnummer. Studiedeltagarna identifierades i samråd med ordinarie personal och 
forskningsintervjun genomfördes av psykiater, psykolog eller psykiatrisjuksköterska. De 
primära utfallsmåtten var suicidförsök och suicid inom ett år från indexförsöket och 
information om dessa inhämtades dels genom journalläsning, dels genom registeruttag. De 
skattningsskalor som undersöktes var: 
 Karolinska Interpersonal Violence Scale (KIVS), som kartlägger utsatthet för och 
användande av interpersonellt våld i barndomen (6–14 år) och vuxen ålder (≥15 år) 
(Studie I och III). 
 Columbia-Suicide Severity Rating Scale (C-SSRS), som karakteriserar suicidtankar 
med avseende på allvarlighetsgrad och intensitet och också värderar förekomst av 
suicidalt beteende och den medicinska allvarlighetsgraden hos genomförda 
suicidförsök (Studie II och III). 
 Suicide Assessment Scale (SUAS), som skattar allvarlighetsgrad i olika psykiatriska 
symtom (bland annat nedstämdhet, ångest, impulskontroll och suicidtankar) 
(Studie III). 
 Suicide Intent Scale (SIS) som värderar omständigheterna vid ett genomfört 
suicidförsök med avseende på bland annat möjlighet att bli upptäckt, avsikt med 
försöket och personens uppfattning om den valda metodens farlighet (Studie III och 
IV). 
I en subgrupp (n=479) jämfördes den prediktiva förmågan hos SIS med den rutinmässiga 
kliniska suicidriskbedömning som gjorts av läkaren i samband med indexförsöket, baserad på 
en sammanvägning av risk- och skyddande faktorer (Studie IV). 
Totalsumman hos respektive skattningsskala användes som prediktor för suicidförsök och 
suicid under uppföljningstiden. Logistisk regressionsanalys, χ2-test och receiver operating 
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characteristics (ROC)-kurvor användes för att undersöka eventuella samband mellan 
prediktorer och utfall, och baserat på de tröskelvärden som identifierats i ROC-kurvorna togs 
sensitivitet, specificitet och andra mått på tillförlitlighet fram. 
Resultat 
Det totala materialet utgjordes av 804 personer varav 541 kvinnor (67 %). Majoriteten (83 %) 
hade gjort ett suicidförsök vid index. Under det första året efter inklusion gjorde 216 personer 
(27 %) ett suicidförsök och 19 (2.4 %) dog i suicid.  
I Studie I undersöktes den prediktiva förmågan hos KIVS bland de 355 personer som 
inkluderats 2012–2014 och som hade gjort ett suicidförsök vid index. Av dess gjorde 78 
personer, 22 %, ett suicidförsök under det första halvåret efter inklusion. En totalsumma på 
sex poäng eller mer predicerade upprepat suicidförsök med 62 % sensitivitet och 53 % 
specificitet.  
I Studie II undersöktes den prediktiva förmågan hos C-SSRS i hela gruppen om 804 individer 
med avseende på upprepat suicidförsök inom sex månader. Totalsumman och delskalan som 
mäter suicidtankars intensitet predicerade utfallet, med som bäst 59  % sensitivitet och 57 % 
specificitet.  
I Studie III jämfördes de fyra skalorna med varandra med avseende på suicidförsök och suicid 
inom tre månader och inom ett år. Totalsummorna på KIVS, C-SSRS och SUAS var 
korrelerade till suicidförsök vid ettårsuppföljningen, och C-SSRS även vid tre månader. 
Totalsumman på SIS var korrelerad till suicid vid båda tidpunkterna. Den prediktiva 
tillförlitligheten var måttlig för alla skalorna.  
I Studie IV jämfördes den kliniska riskbedömningen med SIS med avseende på prediktion av 
suicid inom ett år. Hög risk enligt läkarbedömningen var förknippad med utfallet med en 
oddskvot på 4,1 (95 % konfidensintervall 1,2–13,4) och hög risk enligt SIS (här definierad 
som en totalsumma ≥18) gav en oddskvot på 5,1 (95 % konfidensintervall 1,5–16,8). Båda 
metoderna hade måttlig tillförlitlighet vad gäller sensitivitet, specificitet och positivt 
prediktivt värde. 
Slutsats  
Det finns statistiskt signifikanta samband mellan de faktorer som undersöks med 
skattningsskalorna och upprepat suicidförsök eller suicid. Trots det kan ingen skattningsskala 
predicera de utfallen på individnivå med tillräcklig precision till följd av otillräcklig 
sensitivitet och specificitet. Vad gäller fullbordat suicid är det ett ovanligt utfall också i en 
högriskgrupp, vilket innebär att endast en mycket liten andel av dem som identifieras som 
tillhörande högriskgruppen kommer att ta sitt liv. De faktorer som undersöks med 
skattningsskalorna är välkända riskfaktorer för suicidförsök och suicid och de patienter som 
ingår i studierna har i mycket hög utsträckning fått suicidpreventiva insatser. Detta kan 
innebära att det prediktiva värdet hos skattningsskalorna minskar, och att det inte skulle 
tillföra så mycket att införa skattningsskalorna i ordinarie vård. 
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Dessa resultat är i linje med ett mycket stort antal tidigare studier och talar för att 
suicidprevention genom identifiering av högriskindivider med hjälp av skattningsskalor inte 
torde vara en framkomlig väg. I detta arbete har skattningsskalor undersökts, men det bör 
poängteras att det inte heller med någon annan hittills undersökt metod har gått att ta fram 
prediktionsmodeller för suicidförsök eller suicid som är kliniskt tillförlitliga på individnivå. 
De studier som ingår i avhandlingen ger däremot inte stöd för att skalorna helt saknar 
användningsområden, då det endast är det prediktiva värdet som är undersökt. De skulle t.ex. 
kunna fylla en funktion genom att strukturera och standardisera anamnesupptagningen.  
Det går heller inte att, baserat på resultaten från de presenterade studierna, säga att 
suicidriskbedömning i sig saknar värde. Även om man inte kan förhindra alla suicid genom 
att förutsäga dem kan man identifiera påverkbara riskfaktorer och erbjuda behandling, om 
sådan finns. Att en riskbedömning är inexakt på individnivå är inte unikt för suicid. Detta 
gäller också för andra typer av dödsfall – skillnaden ligger i att suicid verkar uppfattas som 
mer förutsägbara trots att det saknas empiriskt stöd för en sådan ståndpunkt. Detta, liksom att 
det synes finnas ett behov av att hålla någon ansvarig när ett suicid inträffat är intressanta 
fenomen som ligger utanför den aktuella avhandlingens område. 
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